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ABSTRACT
The hemodynamics of the liver with its dual blood supply
is unique. The liver depends entirely on the hepatic artery
to regulate total hepatic flow since the portal vein is unable
to control inflow to the liver. The existence of stable
hepatic blood flow is essential for the maintenance of hepatic
functions. The reservoir (capacitance) function, the
clearance of many compounds (such as hormones) and the
stability of intrahepatic sinusoidal pressure depends on
hepatic blood flow.
It has been long observed that the hepatic arterial flow
responds in a reciprocal fashion to chang-es in portal flow in
order to maintain total hepatic' flow steady, an observation
referred to as the hepatic arterial buffer response. On the
other hand, the occurrence of changes in hepatic arterial
resistance in response to changes in arterial perfusion
pressure (i. e. autoregulation) remains controversial. The
mechanisms underlying both responses have not been fUlly
elucidated, although a myogenic mechanism has been suggested.
This research study was designed first, to quantitate the
hepatic arterial buffer response and the hepatic arterial
autoregulation and second, to examine the likely mechanisms
governing these responses. An anesthetized cat model with
intact liver and intact blood supply was used. The hepatic
arterial autoregulation response and the buffer response were
induced by the use of a micrometer screw-clamp placed around
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the hepatic a~ery and the superior mesenteric artery. Blood
flow in both arteries was measured by electromagnetic flow
probes.
The results indicated that the buffer capacity is
variable. The bUffering efficiency increases with the
decrease in portal flow to reach a maximum value of 24% at 60%
decrease in portal flow. Although further decreases in portal
flow were accompanied by progressive increases in hepatic
arterial conductance, the bUffering efficiency declined. Our
results showed the existence of weak hepatic arterial
autoregulation. Both the buffer response and autoregulation
were found to be mediated through adenosine. A unified
hypothesis has been suggested according to which adenosine is
secreted by specialized cells in the space of Mall close to
the resistance arterioles of the hepatic artery. This
intrinsic dilator can act on the resistance arterioles or be
washed away by portal or hepatic arterial flow. Reduction in
either flow would result in accumulation of adenosine
resulting in vasodilation of the hepatic artery. An increase
in either flow would result in vasoconstriction. our data
support the dilator washout theory.
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1. INTRODUCTION
1.1 GENERAL CONSIDERATIONS
The liver is the largest single internal organ in the
body,weighing 1200 to1800g in the average adult. It is
located under the diaphragm and occupies most of the right
hypochondrium and part of the epigastrium of the abdomen. The
liver is covered completely by a dense connective tissue layer
(Glisson's capsule) that lies beneath the peritoneum.
Blood is supplied to the liver by two routes: the
hepatic artery with well oxygenated blood, and the portal vein
which drains less oxygenated blood from the splanchnic organs
and the spleen. Portal blood contains nutrients absorbed from
the intestinal tract, hormones released from some splanchnic
organs (eg. pancreas) and many other biologically active and
inactive products. The liver is interposed between the
gastrointestinal tract and the general circulation. ThUS,
under normal conditions, all substances absorbed from the gut
and released into the portal blood stream must flow through
the liver before entering the systemic circulation and can be
subjected to presystemic treatment and/or elimination.
Unlike other organs, the liver has more than one major
function. As a part of the digestive system, the liver
synthesizes bile and bile salts to facilitate fat absorption.
It stores, synthesizes and metabolizes nutrient materials.
The liver has a major excretory function; it clears the
circulation of a wide variety of compounds, some of which need
to be converted to less toxic (detoxification) or to
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hydrophilic compounds before excretion. Another major
function of the liver is its hemodynamic role in the systemic
circulation. The hepatic blood vessels contain about 14% of
the total blood volume of the body (Greenway and Lister,
1974) • The liver contracts in response to hypovolemia, as
during hemorrhage, expelling a volume of blood equal to 26% of
the blood volume loss, regardless of the extent of that loss
(Lautt et al., 1980). The hepatic artery contributes
significantly to the hemodynamic function of the liver as will
be discussed later. Other important functions of the liver
inclUde, in brief, blood cell formation (during infantile
life), .plasma proteins synthesis (such as albumin,
prothrombin, etc.) and synthesis of heparin. Liver
synthesizes the. clotting factors and shares in the destruction
of aged red blood cells. The liver is a storage depository
for Vitamin A, D and B12 and for iron. The liver is the
largest store for glucose (as glycogen). The liver acts as a
sensory organ as well. It has receptors for glucose, sodium,
colloid, fatty acids (free long-chain ones), temperature and
pressure. The liver acts as an endocrine gland that controls
blood volume through the secretion of two hormones,
somatomedin and natriuretic hormone, which control sodium salt
excretion from the kidney. The liver is the site of
conversion of some hormones from one form to another, such as
the conversion of some steroid hormones to testosterone,
especially in females. Along with the muscles, the liver
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contributes to. thermoregulation since it produces heat which
is adju.stable to the body requirement. The liver is
responsible for the formation and excretion of urea. Lastly,
the liver acts as a buffer for the glucose level in the plasma
to maintain stable blood sugar.
This work will deal exclusively with the hemodynamic
function of the liver and the significance of the hepatic
arterial contribution to this major function.
To comprehend the hemodynamic function of the liver, a
proper understanding of the hepatic circulation and its unique
microvascular anatomy is required.
1.2 THE·MICROVASCULAR ANATOMY AND FUNCTION
Inside the liver the hepatic artery and portal vein break
up into countless numbers of arterioles and terminal portal
venules. The terminal hepatic arterioles are much smaller in
diameter compared to the terminal portal venules which make
them more resistant to the blood flow. The circulation across
the hepatic sinusoids occurs at a low pressure gradient. The
parallel subdivisions of the hepatic artery and portal vein
are accompanied at their terminal levels by bile ductules,
lymph vessels, and nerves which originate from similar
preterminal structures in a small triangular portal tract
(Rappaport et al., 1954). ThUS, the portal tract is a channel
which contains the terminal portal venules, the hepatic
arterioles and the other terminal structures mentioned above,
3
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THREE.DIMENSIONAl. SCHEMA OF UVER STRUCTURE (AfTER HAH$ ELIAS)
'mtI'ORTAL IlLE DUCTULE (CANAL 0I1lIIINO)
INTRALOIULARIILE DUCtULE
PElIISINUSOlOAl. SPACes (01' DISH)
SlNUSOIDS
Fig. 1 Three-dimensional schema of liver structure. Note
that the space of Mall is referred to in some books as the
periportal space. The artist speculated the presence of
intralobular arterioles. The existance of such arterioles
have not been confirmed histologically. (The CIBA Collection
of Medical Illustrations, Vol. III, The Digestive system, Part
III, Section XV, Plate 6.)
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richly anastomosing labyrinth-like system (Motta et al.,
1978). The sinusoids empty into the terminal hepatic venules,
from which they debouch into the tributaries of the hepatic
venous system. The hepatic veins, thence empty into the
inferior vena cava. Thesinusoids are lined mainly by two
types of cells; the endothelial cells and Kupffer cells, which
are reticuloendothelial cells capable of phagocytizing
bacteria and other foreign bodies in the blood. The
endothelial cells of the sinusoids are a unique type of
endothelial lining consisting of cell bodies with flattened
processes perforated by small fenestrae of about 100nm in size
(range 10 to 200nm in diameter). These fenestrae are arranged
in groups and often called sieve plates (Wisse, 1970). The
endothelial lining of the sinusoids is separated from the
parenchymal hepatic plates by a narrow space called the space
of Disse. Therefore, the space of Disse is bordered, at one
side, by a thin endothelial layer and, at the other side, by
the plasma membrane with its microvilli of the parenchymal
cells. The total space between each two opposing hepatic
plates (i. e. the sinusoidal space + 2 spaces of Disse) is
called the hepatic lacuna. The sinusoidal endothelial lining
lacks a basal lamina and for that reason the fenestrae
constitute an open connection between the sinusoidal lumen and
the space of Disse. It is believed that the major part of the
transport and exchange of fluid, solutes and particles between
the blood and the space of Disse takes place through these
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open sieve plat~s. The space of Disse as such is a unique
form of interstitial space filled with fluid similar to that
of plasma since it is freely accessible to all the large
molecules contained in the plasma. Red cells are larger than
the fenestrae and do not have access to the space of Disse.
Therefore, in the liver, the main barrier between the plasma
and the interior of the hepatocytes is the parenchymal plasma
membrane. The above description brings us to the conclusion
that the sinusoids have a unique structure that allows maximum
contact between the hepatocytes and the blood perfusing the
liver. The distribution of endothelial fenestration
populations is not static. The diameter of the fenestrae can
increase or decrease in response to many physiological and
pathological situations such as hypoxia, blood pressure,
irradiation, endotoxemia, alcoholic intoxication, etc. (Wisse
et al., 1985). Apart from the dynamics of fenestrae diameter,
the kinetics of fenestrae number (fenestrae per square micron)
has been reported as well. Alcohol administration increases
the size, but decreases the number of endothelial fenestrae
(Mak and Lieber, 1984). Normally, the diameter of fenestrae
decreases slightly as we move from sinusoids adjacent to the
portal tract (or triangle), i.e. zone 1, to sinusoids adjacent
to the terminal hepatic venules, i . e. zone 3, whereas the
frequency increases, resulting in an increase in porosity
(Wisse et al., 1985). These gradients in the frequency and
diameter of fenestrae are paralleled by gradients in the
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morphometry of .sinusoids. sinusoids in zone 1 are narrow and
more tortuous than those of zone 3 (5.9uM in zone 1 and 7.1uM
in zone 3 measured from in vivo microscopic preparation)
(Wisseet al., 1985). These findings indicate·. that both red
blood cells (7.32uM in diameter) and white blood cells (mean
of 8.5uM in diameter) are bigger than inlet sinusoids of zone
1. This implies deformation of the cells during passage
through sinusoids from·zone 1 to zone 3, which was observed by
using in vivo microscopy (McCuskey et al., 1979). Red blood
cells pass in a single row and adapt their shape to size
differences and curvitures. White blood cells are less
plastic and do not· adapt easily. Th~y interrupt blood flow
and are either pushed out after mild adaptation or attach to
the endothelium and migrate by active movement. This peCUliar
pattern of movement of blood cells through liver sinusoids
leads to two important hemodynamic observations. First, blood
cells (the white ones in particular) press and squeeze the
space of Disse as they move and massage the endothelial
lining, forcing the fluid content of the space of Disse to
flush out through the fenestrae to the sinusoidal lumen
compartment. This fluid movement will contribute to the vital
process of hepatic uptake and exchange. Second, as a result
of blood cell movement, fluid in the space of Disse along with
the plasma column in the slnusoids is pushed downstream toward
terminal hepatic venules. Since all of the exit points are
adjacent and flow is downstream, flow in adjacent sinusoids is
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concurrent. In,other words, blood .flows in one direction from
the inlet sinusoids in zone 1 to zone 3 and there is no chance
for any biological product released from the liver downstream
to diffuse upstream where the resistance vessels controlling
blood flow are located. This point will be further discussed
later.
The functional hepatic microvascular circulatory unit is
the simple liver acinus (Rappaport, 1973). The acinus is a
small parenchymal mass or glomus, irregular in size and shape,
arranged around an axis consisting of a terminal hepatic
arteriole, terminal portal venule, bile ductule (s), lymph
vessels, and nerves (Figure 2). An acinus lies between two or
more terminal hepatic .venules, the so-called central veins,
with which its vascular and biliary axial channels
interdigitate. The interdigitation of terminal branches
originating from three or more triangular portal spaces around
one terminal hepatic venule may create a vascular pattern
simUlating a hexagon which is the classical histological
appearance of liver sections under the light microscope.
Hence, the difference between the classical liver lobule and
liver acinus is that the liver lobule is the mass of
parenchymal cells and sinusoids that drain into a terminal
hepatic venule (i. e. hepatic central venule) whose cross-
section resembles a hexagon histologically, while the acinus
is a small mass of parenchymal cells nourished by blood
supplied from one triangular portal space or tract (i.e.
9
Terminal
Hepatic
Venule
Fig. 2 The liver acinus (microcirculatory hepatic unit).
Acini cluster like grapes at the ends of portal and arterial
branches. Blood enters the acinus at its centre (zone 1) and
flows outward to drain into a terminal venule at its
periphery. Level of oxygenation decreases as blood passes
from zone 1 to zone 3. (From Lautt, 1977, Gastroenterology
73: 1163-1169.)
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portal venule ~ndhepatic arteriole(s». The liver acinus,
and not .the hepatic lobule, is considered. as the functional
unit since it is the smallest parenchymal mass whose function
is controlled ind.ependently of neighbouring areas. Whereas,
there is no structural nor secretory unity in the imaginary
hexagonal lobule.
The liver acinus is subdivided, according to 02 content,
into three circulatory zones which surround the axial
structure. The periportal microenvironment has the highest 02
tension derived from the terminal hepatic arteriole and is
called zone 1. The perivenular microenvironment is the most
distant from the blood supply and receives blood that has
already exchanged gases (i.e. low 02 tension) and metabolites,
and is called zone 3. Zone 2 is the transitional zone in
between zone 1 and zone 3. It is evident that cells of zone 3
are most sensitive to damage through ischemia, anoxia,
congestion, and nutritional deficiency (Rappaport, 1963). The
changes in living conditions between cells in zone 1 and 3,
due to arterial irrigation and 02 gradient that decreases
toward zone 3, has been translated as change in the metabolic
activities of these zones. Zone 1 enzymatic activity is
preferentially geared to synthetic (eg. protein and glycogen)
and regenerative processes. Whereas catabolic processes (eg.
fat, drugs and pigment) are facilitated and enhanced in zone 3
(Jungermann and Sasse, 1978). Metabolic and enzymatic
activity of zones 1-3 should not be considered as having a
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static distribution. Necrosis of the parenchymal cells in one
zone leads to a shift of the metabolic function to the healthy
cells of the neighbouring zone (Sasse, 1975).
1.3 HEPATIC VASCULATURE
The interposition of the liver between the gastro-
intestinal tract and the general circulation, makes the liver
obliged to receive all the blood outflow from the gastro-
intestinal tract and the spleen. In other words, the liver is
unable to control its portal blood inflow which can only be
regulated through blood vessels feeding the gastrointestinal
tract and the spleen (i.e. superior and inferior mesenteric
arteries, splenic artery, celiac artery , etc.). Therefore,
the only way for the liver to control or regulate its total
blood flow is through the hepatic artery. The hepatic artery
is a dynamic vessel and capable of such regulation. Hepatic
arterioles and terminal hepatic arterioles have muscular walls
and sphincters which enable the arterioles to regulate flow,
pressure, oxygen content and tension in the microcirculatory
unit they supply (Rappaport, 1981).
The presence of unmyelinated nerve fibres along with the
smooth muscle cells in the wall of the arterioles enable these
microvessels to constrict or dilate in response to nerve
stimulation. The liver is richly innervated with nerve
fibres. This innervation is through the anterior and
posterior hepatic plexuses. The anterior plexus is the
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smaller and lies in close association with the hepatic artery
and is composed of sympathetic postganglionic fibres whose
preganglionic counterparts arise from T7-T10 (Lewis, 1951).
The posterior plexus lies at the posterior aspect of the
portal vein. It includes a group' of postganglionic
sympathetic fibres from the right celiac ganglion. The
preganglionic origin arises from T7-T10 as well. Both
plexuses are interwoven (Lewis, 1951). The hepatic artery is
innervated exclusively by the sympathetic fibres, whereas the
bile ducts are innervated by both sympathetic and
parasympathetic fibres (Rappaport, 1975) • Electrical
stimulation of the hepatic nerves leads to a marked decrease
in hepatic arterial conductance (i.e. vasoconstriction) in a
frequency-dependent manner (Greenway and Stark, 1971). This
vasoconstrictor response is mediated by alpha adrenergic
responses and can be completely blocked by phentolamine
(Greenway and Stark, 1971). As with the arterial response,
the portal vessels are under alpha adrenergic control which
results in a rise in portal pressure when the hepatic nerves
are stimulated (Lautt, 1979).
Other than its neural response, the hepatic artery
responds with constriction or dilation to many pharmacological
agents such as norepinephrine, epinephrine, angiotensin,
vasopressin, glucagon, bile salts, isoproterenol, adenosine,
histamine, etc. (Greenway and stark, 1971). From a functional
or physiological point of view, it is clear now that extrinsic
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regulation of ~he hepatic microcirculation occurs mainly via
the hepatic arterioles through nerve stimulation, hormones and
bile salts (Rappaport, 1981).
It has been mentioned that the portal tract (i. e • the
vascular stalk of the liver acinus) contains some lymphatic
vessels. These lymphatics are part of the intrahepatic
lymphatics. The intrahepatic lymph is drained through fine
periportal venous and perihepatic venous channels. Both fine
intrahepatic lymphatic routes . communicate directly with the
extremely large capSUlar lymphatics (i.e. lymphatics of
Glisson's capSUle) (Magari et al., 1979). The space of Disse
has no direct communication with the lymphatics (Magari et
al., 1979). This observation leads to the speCUlation that
lymph passes from the space of Disse to the space of Mall
(where lymphatic terminals are found) through gaps between the
cells of the limiting plate. To the best of my knOWledge, the
data available on liver lymphatics do not prove or disprove
the presence of functional relationships between periportal
vein lymphatics and hepatic arterioles, nor between them and
microvascular blood flow.
The cirCUlation across the liver occurs at a low pressure
gradient. The pressure drop from the terminal portal venules
(S-9mmHg) to the hepatic veins (1-4mmHg) is less than 5mmHg.
However, the pressure inside hepatic sinusoids is kept close
to that of the portal vein through the existence of
postsinusoidal resistance (Lautt, Greenway et a1., 1986; Lautt
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et al., (in press) ; Greenway et ale , 1985). The
postsinusoidal resistance site is within the small hepatic
veins prior to their entry into the hepatic veins proper
(Lautt, Greenwayetal., 1986). It is essential to have a
maintained basal.level of sinusoidal pressure close to that of
portal pressure to keep the integrity of a spongy organ like
the liver and to prevent the collapse of some hepatic
sinusoids. In addition to its role in maintaining the basal
transmitted to the sinusoidal (lobar)
(Lautt et ale , (in press) ) . Mitzner
sinusoidal pressure, the postsinusoidal resistance inhibits or
buffers to some extent the effect of the physiological
fluctuations in central venous pressure (3-5.5mmHg) from being
or portal pressure
(1974) previously
suggested that hepatic postsinusoidal resistance acts as a
starling-resistor. The Starling-resistor waterfall model
predicts that upstream blood pressures are absolutely
protected against changes in downstream pressure until some
critical pressure is reached and beyond that pressure, further
increments in downstream pressure will be fully transmitted
upstream. However, the situation is not so in the liver. The
pressure transmission from central venous pressure (CVP) to
sinusoidal (lobar) venous pressure begins with small rises in
central venous pressure and becomes greater as the rise in
central venous pressure increases. Changes in CVP in the face
of higher postsinusoidal resistance will be weakly transmitted
upstream but this is due to reduced proportion of transmission
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over the enti~e pressure range and not due to having to
overcome a higher waterfall pressure (Lautt, Legare etal.,
1986).
At normal portal flow and pressure no significant
presinusoidal resistance seems to exist (Lautt, Greenway et
al., 1986). Some sig.nificant presinusoidal resistance can be
generated and maintained if portal flow is greatly increased
(Greenway et al., 1985) or when vasoactive agents such as
norepinephrine and angiotensin are administered (Lautt et al.,
(in press». However, the main rise in portal and sinusoidal
pressure seen with hepatic nerve stimulation and
vasoconstrictor hormone administration (such as norepinephrine
and angiotensin) occurs at the postsinusoidal site within the
hepatic veins (Lautt et al., (in press)).
1.4 HEPATIC CIRCULATORY HOMEOSTASIS AND LIVER FUNCTION
The stability of the hemodynamic and metabolic function
of the liver is crucial to body homeostasis. Any change in
the clearance function of the liver, for example, leads to
change in plasma concentrations of many biological s.ubstances
that can affect the well-being of the body. It seems from
many observations that the stability of liver function depends
on the maintenance of a stable intrahepatic pressure and a
steady hepatic blood flow. Therefore, intrahepatic blood
pressure and hepatic blood flow should be immune or as
insensitive as possible to the passive effects of changes in
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portal blood flow or cardiac output. Since the liver has no
control over its portal··flow, which is subject to chang-es from
minute to minute, the only way for the liver to maintain its
total blood flow is by changing its hepatic arterial flow.
This relatioship is not a theoretical necessity, in fact it is
a reality. It has been long observed that the hepatic
arterial flow is consistently related to portal blood flow.
As portal flow changes, hepatic arterial flow changes in the
opposite direction to maintain steady total hepatic blood flow
(Burton-opitz, 1911). For further understanding of the
important central role of the hepatic artery in maintaining
stable liver function and thereafter in maintaining body
homeostasis, related liver functions will be discussed
individually.
1.4.1 The Capacitance Function of the Liver
The splanchnic bed is a maj or blood reservoir in the
body. It is formed from three important components namely the
liver, the intestine, and the spleen. In humans, it seems
that the spleen is unimportant and the liver and intestine
appear to be the important blood reservoirs (Price et al.,
1966) • A major portion of the splanchnic blood volume is
contained in the hepatic venous circuit. The hepatic venous
bed is under the control of the sympathetic nervous system
(Greenway and Stark, 1971). Direct nerve stimulation results
in a rapid and massive expUlsion of blood from the hepatic
venous circuit (up to 50% of the blood volume of the liver)
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into the systemic circulation (Bennett et al., 1982).. In
acute hypovolemia, as during hemorrhage, the liver contracts
and expells.a volume of blood equal to 26% of the hemorrhaged
volume regardless of the extent of hemorrhage (Lautt etal.,
1980) • Whereas, in hypervolemia the hepatic venous circuit
accommodates 26% of the volume load. This indicates that the
capacitance function of the liver as a blood reservoir is
important to the cardiovascular homeostasis as a whole.
However, it should be pointed out that intact nerve supply to
the liver is not essential for the hepatic capacitance
response to operate at normal hepatic venous pressure.
Denervated or alpha adrenergically blocked liver can still
expell blood in response to hemorrhage. Nephrectomy,
hypophysectomy, and adrenalectomy also do not affect this
response (Lautt et al., 1980). The decreases in hepatic blood
volume are linearly related to reductions in hepatic blood
flow regardless of the reason for that reduction. In other
words, at normal hepatic venous pressure the hepatic
capacitance ,function is regulated primarily by hepatic blood
flow. Other factors that can affect the hepatic capacitance
function (such as sympathetic nerve stimulation and vasoactive
hormones) are redundant mechanisms. These redundant active
mechanisms become the prime regulator of the capacitance
response when the passive responses to decreased hepatic blood
flow are reduced, such as during raised hepatic venous
pressure (Lauttet al., 1980). It is not clear whether the
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passive capacit,ance response is due to the chan.ge in hepatic
blood flow per se or to the resultant change in the
intrahepatic pressure. Recent studies suggest that
intrahepatic pressure is the key factor in initiating the
capacitance response (Bennett and Rothe, 1981; Greenway et
al., 1985; Lauttet al., 1980). Liver capacity increases when
hepatic venous pressure, and hence intrahepatic pressure,
rises and portal flow is held constant (Greenway et al.,
1985). However, no study overruled the role of hepatic flow
per se on passive hepatic capacitance response. Such study
should allow the measurement of changes in the hepatic
reservoir capacity in response to changes in hepatic blood
flow without changing the intrahepatic pressure. Regardless
of the outcome of such study, the role of the hepatic artery
in stabilizing the capacitance function of the liver is
evident. Any local change' in portal flow, and hence in
hepatic blood flow, will be corrected for by changes in
hepatic arterial flow in the opposite direction to keep the
hepatic blood flow (and intrahepatic pressure) steady.
Thence, liver volume will be held steady. otherwise, any
change in hepatic blood flow will be followed by an increase
or decrease in the venous return to the heart. such changes
in venous return will be tran.slated as change in cardiac
output that will affect the whole cardiovascular homeostasis.
Hence, through stabilizing the capacitance (reservoir)
function of the liver, the
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hepatic artery stabilizes the
overall cardiovascular hemodynamics indirectly (Greenway,
1983).
1.4.2 The Clearanc@ Function of the Liver
Hepatic clearance of a wide variety of compounds,
including hormones, is blood flow dependent. Reduction of
hepatic blood flow is known to decrease hepatic clearance of
many compounds such as sulfobromophthalein, indocyanine green,
collodial gold, galactose, lidocain, denatured albumin,
colloidal chromium phosphate, oxyphenbutazone; and endogenous
compounds such as aldosterone, cortisol, 11:""deoxycortico-
sterone, corticosterone, and progesterone (Lautt, 1985).
Since total hepatic blood flow determines hepatic clearance
rates of many endogenous substances, including hormones,
therefore, it is essential, for hormonal homeostasis, to have
stable hepatic blood flow and it must not be allowed to be
sUbject to the wide fluctuations of portal venous blood flow
that occur continuously in response to postural and emotional
changes and to variable metabolic states of the splanchnic
organs. It has been mentioned above that the liver maintains
its blood flow stable via changing the flow in the hepatic
artery. Therefore, the hepatic artery controls indirectly the
clearance function of the liver and its role is especially
significant for the homeostasis of hormones which have very
high turnover rates, i. e. where the rate of' catabolism is an
important determinant of the plasma levels of such hormones.
Two unique characteristics of the hepatic cirCUlation are
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compatible witl?- this putative role of the hepatic artery.
First, the hepatic arterial flow is independent of liver
met.abolic activity (Lauttand Daniels, 1983; Lautt, 1980;
Lautt, 1977b). When hepatic and intestinal metabolic rate is
acutely stimulated (by use of dinitrophenol) oxygen uptake by
the liver and gut increases. The gut responds to the
increased oxygen demand by vasodilation resulting in increased
portal flow and oxygen delivery to the gut. The hepatic
artery shows no tendency for dilation despite the great
reduction in portal and hepatic venous oxygen content and
partial pressure (Lautt, 1980). However, the hepatic artery
responds to the increase in portal flow by vasoconstriction
reSUlting in holding the total hepatic blood flow· constant.
The liver maintains the high metabolic rate by increasing
oxygen extraction in the face of reduced oxygen delivery
(Ede1stone et al., 1984; Lautt, 1980). Similar conclusions
can be derived from the isovolemic hemodilution studies
(Lautt, 1977b). In that study the oxygen delivery to the
liver and gut is reduced. The arteries supplying the gut
dilate and result in increased portal flow. Oxygen delivery
to hepatocytes is decreased, however, the hepatic artery shows
a small constriction and maintains total hepatic blood flow
steady. Again, the hepatic metabolism is maintained as a
result of increased oxygen extraction. stimulation of liver
parenchymal cell metabolic activity by low doses of
taurocholate (bile salt) produces no vascular responses (Lautt
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and Daniels, 1983). At higher doses the hepatic artery
dilates in addition to the stimulation of parenchymal cell
metabolism. The hepatic artery dilation is greater if bile
salt is administered via the hepatic artery compared to that
of portal vein administration. Therefore, the vascular and
metabolic effects of bile salt are independent (Lautt and
Daniels, 1983).
Compounds reaching the liver from the systemic
circulation are equally accessible to hepatic parenchymal
cells, regardless of their route of entry to the liver. Equal
doses of taurocholate administered through the hepatic artery
and portal vein are equally effective in stimulation of
hepatic bile flow (Lautt and Daniels, 1983). Indocyanine
green is equally well extracted as well by the liver
regardless of its route of administration (Lautt et al.,
1984) • These two observations indicate that changes in
hepatic arterial flow in response to changes in portal blood
flow (to maintain steady hepatic blood flow, and thence,
steady hepatic clearance) do not affect the pattern of
intrahepatic irrigation of parenchymal cells. The liver
normally receives much more oxygen than it requires and in
cases of reduced hepatic arterial supply, the liver can
readily extract more oxygen to compensate for altered delivery
(Bredfeldt et al., 1985; Edelstone et al., 1984; Lautt, 1980).
Therefore, it is rational to conclude that the hepatic artery,
rather than being subservient to hepatic metabolic demands, is
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the guardian·of.humoral clearance rates.
1.4.3 stability of Intrahepatic Pressure
The hepatic artery seems to play an important role in
stabilizing intrahepatic (sinusoidal) pressure. The venous
circuit of the liver has no autoregulation capacity and the
intrahepatic pressure therefore, depends on hepatic blood flow
(Greenway et al., 1985; Richardson and withrington, 1978).
The relationship between intrahepatic pressure, hepatic blood
flow and liver volume is linear (Greenwayet al., 1985) •. The
relationship between the hepatic arterial flow and portal
flow, which tends to hold total hepatic flow steady,
stabilizes the intrahepatic pressure. This has been
demonstrated clearly in porta-systemic shunt procedures. In
patients with portal hypertension and normal liver function
tests, portacaval shunts cause an insignificant drop in portal
pressure despite the significant decrease in hepatic portal
inflow (Zimmon and Kessler, 1980). In these shunt procedures,
the hepatic arterial flow increases to compensate for the
decrease in portal flow and holds the total hepatic flow and
intrahepatic pressure steady and close to their control
levels. It was observed that failure of the hepatic artery to
maintain the intrahepatic pressure after portacaval shunt
procedure is a poor prognostic sign for patients with portal
hypertension. In such patients portal pressure of 25cm H20
(18nunHg) is a critical lower limit of pressure, below which
hepatic function is not maintained and chronic encephalopathy
23
with early dea1;hsupervenes (Zimmon and Kessler, 1980). The
ability of the hepatic artery to hold portal pressure above
25cm H20 after portacaval shunting, even if portal flow is
retrograde, is a good prognostic sign and normal liver
function is expected postoperatively (Zimmon and Kessler,
1980).
The existence of stable intrahepatic pressure is
important for the stability of fluid exchange function of the
liver. 'Elevated intrahepatic pressure produces a filtration
of high protein fluid from the plasma to the surface of the
liver and then into the peritoneal cavity (as with ascites
that accompanies congestive heart failure and liver
cirrhosis). This filtration is maintained for as long as the
intrahepatic pressure is raised and it is directly
proportional to the rise in intrahepatic pressure. It seems
that there are no protective mechanisms to limit filtration
that occurs in the liver as they do in the intestines and
skeletal muscle (Greenway and Lautt, 1970). The sites of such
filtration are still unclear. However, it is possible that
fluid forces its way to the surface of the liver since
hepatocytes are arranged in one-cell thick hepatic plates and
fluid would pass from one space of Disse to another. Acute
liver congestion and fluid filtration are accompanied usually
by marked reduction in bile flow that do.es not recover for
hours after the restoration of intrahepatic pressure (Greenway
and Lautt, 1970). This may indicate disruption of the bile
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canaliculi wit~ passage of the bile into the plasma or lymph
instead of into the bile ducts.
The rise in intrahepatic pressure during hepatic nerve
stimulation is not associated with fluid filtration. On the
contrary, hepatic nerve stimulation reduces the capillary
filtration coefficient (Greenway, 1981) • The possible
mechanism is still unclear. It is anticipated that
sympathetic nerve stimulation decreases sinusoidal
permeability and closes the gaps in limiting plates between
the space of Disse and the space of Mall which limits lymph
outflow.
The stability of the intrahepatic and portal pressure is
not esential for liver function alone. Changes in
intrahepatic and portal pressure can be reflected reflexly or
non-reflexly on the function of other organs too.
Experimentally-induced presinusoidal portal hypertension is
associated with an increase in intestinal blood flow
(Groszmann et al., 1982). On the other hand, elevated
intrahepatic pressure (as during liver congestion) is
associated with a decrease in gut blood flow (Lautt, 1977a).
These findings suggest possible existence of a liver-gut
neural axis.
An increased portal pressure (less than 15cm H20 )
elevates urine flow rate within seconds, a response that can
be blocked by renal nerve blockade (Ohm and Haberich, 1969).
Portal pressure elevations beyond 150m H20 induce antidiuretic
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effect (Liang, 1971). An increase in intrahepatic pressure,
rather than an increase in portal pressure, produces a
consistent reduction in urine flow, Na+ excretion, and
cortical renal blood flow (Levy, 1974). This effect, however,
is believed to be a humoral and not a neural reflex since the
restoration of renal function requires more than 30 minutes
after the restoration of intrahepatic pressure (Levy, 1974).
Regardless of the meChanism, the impact of intrahepatic and
portal pressure on renal function is clear. This observation
may explain the water and salt retention that accompanies
hepatic congestion in congestive heart failure.
1.4.4 The Prevention of Hypoxemic state
The liver normally receives oxygen more than its
requirement and can readily extract more oxygen to compensate
for reduced delivery (Bredfeldt et al., 1985; Edelstone et
al., 1984; Lautt, 1980). It has been mentioned above that the
hepatic arterial flow is not regulated by hepatic parenchymal
cell metabolism. Therefore, under normal conditions,
parenchymal cells will not be adversely affected if hepatic
arterial flow decreases to counterbalance an increase in
portal flow. However, in situations where total hepatic flow
is greatly reduced despite the compensatory increase in
hepatic arterial flow (as during decreased cardiac output),
oxygen's protective role of the hepatic artery is of paramount
importance. It has been calculated that an increase in
hepatic arterial flow to compensate just for 24% of the
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decrease in portal flow is enough to hold total oxygen supply
to. the liver almost steady and offers protection from the
hypoxemic state (BlU1l\qart et al., 1977). The hepatic arterial
protective role can be of importance as well, despite normal
cardiac output, in other cases of reduced oxygen supply such
as severe anaemia orbeinq in a hypoxic environment.
1.5 THE HEPATIC ARTERIAL BUFFER RESPONSE
The relationship. between the portal flow and hepatic
arterial flow which tends to maintain steady total hepatic
blood flow, has been described by many terms. The term
'reciprocal relationship' between the hepatic artery and
portal vein has been used in some papers. In others the term
'autoregulation of the hepatic artery' was used.
Nevertheless, such terms are not appropriate and do not
reflect the true relationship between portal and hepatic
arterial flows. Reciprocity implies that a decrease in portal
flow is accompanied by an increase in hepatic arterial flow
and vice versa. However, this relationship is operating in
one direction. The hepatic artery responds to changes. in
portal flow, but portal venous flow does not respond to
changes in hepatic arterial flow (Egbert and Raber, 1952). On
the other hand, the term 'autoregulation' may be misleading
since the term 'autoregulation of the hepatic arterial flow'
is used as well to describe the pressure-flow relationship in
the hepatic artery regardless of the flow in the portal vein.
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The. mostapprop.riate terminology to describe the relationship
between the hepatic artery and portal vein is 'the hepatic
arterial buffer response'. This terminology was introduced by
Lautt (1981) and defines the hepatic arterial buffer response
as "the inverse control of the portal blood flow over hepatic
arterial conductance independent of hepatic metabolic
requirements". The term hepatic arterial buffer response will
be used in this thesis. Figure 3 is an illustration of the
hepatic arterial buffer response in the cat. The superior
mesenteric arterial flow (SNAP) represents portal flow in this
preparation. Point A and E represent the control state, point
B represents the drop in SMA (portal) flow with the
concommitant rise in the systemic (femoral) and hepatic
arterial pressure and increase in hepatic arterial flow, point
C represents the buffer response when the hepatic arterial
pressure is returned back to the control level using an
arterial clamp and there is still an increase in hepatic
arterial flow, point D represents the release of the SMA
occlusion (notice the SMA hyperemic overshoot and the
corresponding drop in the hepatic arterial flow and systemic
and hepatic arterial blood pressure). The significant roles
of the hepatic arterial buffer response have already been
discussed above under the subject of hepatic circulatory
homeostasis and liver function.
From a historical perspective, the hepatic arterial
buffer response was first noted by Burton-opitz (1911),
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Fig. 3 Trace of the hepatic arterial buffer response taken
from one anesthetized cat. Reduced superior mesenteric
arterial flow (portal flow) results in a sudden rise in
hepatic arterial flow in order to maintain stable total
hepatic blood flow (for description of details refer to text).
SMA = superior mesenteric artery.
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followed by Barcroft and Shore (1912), when they tried to
maintain a steady hepatic arterial perfusion pressure during
the exclusion of the portal circulation. since then the
hepatic arterial buffer response received spotty attention
with some authors in support and others being unable to detect
the response. It seems that the methodology plays a
significant role in confirming or denying such a response.
Data derived from isolated perfused liver or from long-
circuited hepatic artery preparations show absent or weak
hepatic arterial buffer response (Burton-opitz, 1911; Barcroft
and Shore, 1912; Hanson, 1964; Hanson and Johnson, 1966;
Sancetta, 1953; Shoemaker, 1964; Condon, Nyhus et al., 1962;
Price et al., 1964; Takeuchi et al., 1966; Lutz et al., 1968).
Observations made in preparations in which the hepatic artery
was not long-circuited (i.e. intact) showed significant
hepatic arterial buffer response in anesthetized (Ackroyd et
al., 1966; Cohn and Kountz, 1963; Drapanas et al., 1960;
Ternberg and Butcher, 1965) and conscious animals (Price et
al., 1965). In human studies, the hepatic arterial buffer
response has been observed as an abrupt compensatory increase
in hepatic arterial flow during acute portal flow diversion at
the creation of a portacaval anastomosis in portal
hypertension patients (Zimmon and Kessler, 1980; Burchell et
al., 1976; Schenk et al., 1962; Ferguson, 1963; Burchell et
ale , 1974). As mentioned previously, the failure of the
hepatic artery to show the arterial buffer response after the
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shunting procedure is a poor prognostic sign and an indication
of a possible early postoperative death and encephalopathy
(Burchell et al., 1976; Zimmon and Kessler, 1980).
The hepatic arterial buffer response can be observed in
many experiments conducted on the liver, although such
preparations were designed to study functions other than the
hepatic arterial buffer response per see The hepatic arterial
buffer response is put in action when such experiments induce
changes in portal flow. Some of such preparations will be
discussed later. However, in other groups of experiments the
role of the hepatic arterial buffer response can be concluded
indirectly. Infusion of angiotenisn into the hepatic artery
causes marked vasoconstriction and increases hepatic arterial
resistance (Greenway and Stark, 1971). When angiotensin is
administered by intravenous infusion, hepatic arterial flow
decreases as well as portal flow due to intestinal and splenic
vasoconstriction (Cohen et al., 1970). The vasoconstriction
is less marked in the hepatic arterial bed than in the
intestine and spleen, probably because the direct effect of
angiotensin on the hepatic arterioles is counteracted by the
hepatic arterial buffer response triggered by the fall in
portal flow (Cohen et al., 1970). The same analogy can be
used to describe the effect of vasopressin on the hepatic
arterial bed. The direct action of vasopressin on the hepatic
arterial bed is vasoconstriction but this is small and
variable (Greenway and Stark, 1971; Peter et al., 1962;
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Shoemaker, 196~). Intravenous infusions of vasopressin
decrease portal flow, portal pressure and total hepatic flow
due to vasoconstriction in the splenic and intestinal vascular
beds (Cohen et al ., 1970 ; Peter et al., 1962 ; Shoemaker,
1964), whereas hepatic arterial flow increases (Heimburger et
al., 1960). It seems most likely that vasopressin has a weak
vasoconstrictor effect on the hepatic arterial bed, but this
vasoconstriction can be overcome by the dilator hepatic
arterial buffer response initiated by the reduction in portal
flow (Cohen et al., 1970).
Adenosine is a powerful dilator of the hepatic artery and
the superior mesenteric artery. However, intravenous
infusions of adenosine increase portal flow and pressure (by
intestinal vasodilation) and cause negligible changes
(Greenway and Stark, 1971) or marked decrease (Lagerkranser et
al., 1984) in the hepatic arterial flow. contrary to the
effect of vasopressin and angiotensin, it seems that adenosine
increases portal flow and thence initiates a vasoconstrictor
hepatic arterial buffer response. This vasoconstriction may
neutralize or overcome the direct dilator effect of the
circulating adenosine on the hepatic artery.
The impact of the hepatic arterial buffer response can be
predicted as well from the hemorrhage-induced hemodynamic
changes in the liver. After hemorrhage, portal flow decreases
due to arteriolar vasoconstriction in the spleen and
intestine. The splenic vasoconstriction is due to activity of
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the sympatheti.,c nervous system (i. e. the increase in
sympathetic tone), angiotensin and vasopressin (antidiuretic
hormone, ADH) (Greenway and Stark, 1969). In the intestinal
vascular bed, the vasoconstriction is due principally to the
actions of angiotensin and vasopressin, while the increase in
sympathetic tone plays at most a minor role (McNeil et al.,
1970). The decrease in portal flow is proportionally greater
than the decrease in total hepatic flow. Hepatic arterial
flow is either unchanged or increased in spite of a fall in
arterial pressure; hepatic arterial resistance consistently
decreases (Greenway and Stark, 1971). The mechanism of the
vasodilation is not clear. However, it is highly suggestive
that the reduction in portal flow stimulates the hepatic
arterial buffer response to induce dilation of the hepatic
artery. The existence of other factors which contribute to
the dilation cannot be excluded at this stage.
What is the mechanism of the hepatic arterial buffer
response? Many hypotheses have been suggested by many
authors. These hypotheses are illustrated in Figure 4. The
physical analog has been suggested (Ternberg and Butcher,
1965) and considers the hepatic arterial buffer response as
the mechanical effect of the interposition of a slower flowing
portal stream into the path of a faster flowing arterial
stream. Decrease in portal flow is equivalent to removal of
an impedance, and the rate of flow in the hepatic artery
should increase. Conversely, if portal flow increases, its
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Sinusoids
PV HA
THV
Physical Analogue
Neural· Control
Myogenic Control
Metabolic Control
Quality of Portal
Blood
Washout Hypothesis
Fig. 4 The possible mechanisms for linking blood flow control
in the hepatic artery (HA) to flow in the portal vein (PV)
such that total hepatic flow (THV) remains constant.
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impedance to the hepatic arterial flow increases as well,
therefore, a decrease in hepatic arterial flow should result.
Such a mechanical hypothesis implies that the hepatic arterial
flow is an impetus to the portal flow and an increase or
decrease in the hepatic arterial flow produces an increase or
decrease in portal flow respectively. This mechanical
hypothesis cannot be accepted for two reasons. First, many
researchers failed to detect the hepatic arterial buffer
response in isolated perfused ~iver or long-circuited hepatic
artery preparations as mentioned above. Second, occlusion of
the hepatic artery does not cause a significant change in
portal flow in normal humans during surgery nor in patients
with portal hypertension (Egbert and Raber, 1952). My
personal observation in our laboratory supports thisfindinq.
The neural control hypothesis implies that such control
of the buffer response could occur via'an extrahepatic and/or
an intrahepatic nerve network. Complete extrinsic denervation
does not eliminate the buffer response (Lautt, 1981; Mathie et
al., 1980; Sancetta, 1953). There is no anatomical evidence
to support the existence of an intrinsic hepatic nerve
network. Moreover, the hepatic arterial buffer response is
absent in the isolated perfused liver while the vasculature is
able to respond normally to the vasoconstrictor effect of the
hepatic sympathetic nerves when electrically stimulated. It
seems highly unlikely that such a preparation prevents
function of an intrinsic nerve network while still allowing
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the extrinsic nerves to function normally.
The myogenic control hypothesis was believed to be the
mechanism behind the hepatic arterial buffer response for some
time (Hanson and Johnson, 1966). Such a hypothesis suggests
that a rise in transmural pressure across the arteriolar wall
causes an increase in the rhythmic myogenic activity of the
smooth muscle in the wall. The overall effect of such an
increase in activity is vasoconstriction (Mellander and
Johansson, 1968). In other words, such a hypo.thesis is based
on changes in the sinusoidal pressure to explain vasoactive
changes in terminal hepatic arterioles. A rise in sinusoidal
pressure (as a result of an increase in portal blood flow)
causes hepatic arterial vasoconstriction and a fall in
sinusoidal pressure causes vasodilation. However, recent
stUdies suggest that the hepatic arterial flow changes in
response to changes in portal flow despite the stability of
portal (and thence sinusoidal) pressure. Hemodilution causes
a rise in portal flow but portal pressure remains unchanged
(Lautt, 1977b). There is correlation between changes in
arterial flow and changes in portal flow but not with changes
in portal pressure or arterial pressure. The stability in
portal venous pressure is maintained as a result of increased
vascular conductance within the liver. Similarly, the
stimulation of gut metabolism by dinitrophenol causes
elevation in portal blood flow while portal blood pressure
remains steady (Lautt, 1980). The hepatic artery constricts
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to offset elevated portal venous blood flow, thereby.
maintaining total hepatic blood flow constant. Portacaval
shunting procedure in some portal hypertensive patients
results in decreased portal venous flow, increased hepatic
arterial flow and stable prehepatic portal venous pressure
(Zimmon and Kessler, 1980). The existence of the hepatic
arterial buffer response despite the stability of portal (and
sinusoidal) pressure contradicts the explanation of the
myogenic hypothesis of the ,hepatic arterial buffer response.
However, these data do not exclude the possible existance ofa
myogenic control for the hepatic artery.
The metabolic control hypothesis is based on the
formation of vasoactive byproduct by hepatocytes in response
to reduced portal flow. h d " ·On the other an, an 1ncrease 1n
portal flow will be translated as less hypoxia and less
formation of vasoactive metabolic byproduct. However, it is
evident from the previous discussion that the hepatic artery
does not function in a similar manner to other arteries; i.e.,
the hepatic arterial blood flow is not controlled by the local
metabolic needs of hepatocytes and does not dilate in response
to reduced oxygen delivery. The microanatomy of the liver
supports this physiological finding. All blood flow inputs
enter the acinus at the centre; flow in adjacent sinusoids is
concurrent, and all of the exit points are adjacent with no
opportunity for shunting of oxygen (from zone 1 to zone 3
where blood drains into terminal hepatic venules). Similarly,
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back diffusion ~fmetabolites from the periphery of the acinus
to its central part, where. the resistance vessels controlling
blood flow are located, is also precluded, thus preventing a
dilator substance in the venous blood from affecting the
hepatic arterioles upstream.
The quality of portal blood hypothesis suggests the
possible existence of a vasoconstrictor substance released
into portal blood by splanchnic organs. Elevation of portal
flow might then deliver more constrictor to the hepatic
vasculature and result in arterial constriction. Reduction of
portal flow, on the other hand, means delivery of less
constrictor to the hepatic arterioles and dilation should
result. Such a hypothesis can be tested by replacing portal
blood by vena caval blood. A pilot study has been performed
in our laboratory where crossover experiments allow the portal
blood to be shunted into the vena cava and the vena caval
blood to be shunted into the portal vein (Lautt, 1981). The
shunt could be shifted quickly so that the liver could be
perfused with either portal or vena caval blood. The buffer
response was equally sensitive regardless of whether the liver
was perfused with portal or vena caval blood. Thus the factor
controlling the hepatic arterial buffer response appears to be
blood flow per se and not its quality.
One hypothesis remains to be fully evaluated, the dilator
washout hypothesis. This hypothesis proposes that a dilator
substance is produced in the vicinity of the smooth muscle
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cells of the h~patic arterial resistance vessels in the space
of Mall. The dilator is free to interact with receptors on
the muscle or to diffuse out of the cell and be washed away by
the bloodstream (Figure 5). Reduction of portal blood flow
would result in less washout and the accumulated dilator
substance would result in arterial dilation. Conversely, an
increase in portal blood flow would result in more washout and
the low concentration of the dilator substance would result in
arterial constriction. Such a hypothesis .implies that portal
blood must have access to the hepatic arterial resistance
vessels so that portal flow can wash away such dilator from
the area of the resistance vessels. However, this condition
is readily fulfilled. Infusion of vasoactive substances into
the portal blood results in effect on the hepatic artery and
vice versa (Richardson and Withrington, 1981). Although the
anatomical relationship may be unclear, it is evident that
portal blood does have access to the hepatic arterial
resistance vessels. To test the dilator washout hypothesis
three criteria must be met: 1) the substance that can be
washed away by portal blood must dilate the hepatic artery; 2)
potentiators of the exogenous doses of such a dilator should
also potentiate the buffer response; 3) blockers of the
exogenous doses of such a dilator should also inhibit the
buffer response.
What is the dilator SUbstance? In a series of
preliminary experiments conducted in our laboratory in attempt
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Fig. 5 Schematic description of the washout theory: Locally
produced adenosine has access to the hepatic portal and
arterial resistance sites in the presinusoidal vicinity.
Decreased hepatic blood flow leads to less wash out and
accumulation of adenosine that results in hepatic arterial
vasodilation. The effect of altered portal blood flow on
local adenosine concentration accounts for the mechanism of
hepatic arterial buffer response. The effect of altered
hepatic arterial blood flow on local adenosine concentration
accounts for the mechanism of hepatic arterial autoregulation.
(Lautt et al., 1985).
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to interfere with the hepatic arterial buffer response by
using blockers or potentiators, it appears that atropine,
propranolol, ouabain, aminophylline, theophylline,
indomethacin, metiamide and mepyramine do not interfere
significantly with the normal buffer response (Lautt, 1983).
One compound, di12yridamole (an adenosine uptake inhibitor),
has been shown to enhance the buffer response. Although such
observation needs further support, it nevertheless suggests
that the dilator may be adenosine (Lautt, 1983). This
suggestion is attractive. It is well known that after
hemorrhage, peripheral resistance increases due to generalized
arteriolar vasoconstriction. However, three arteries are
spared from the constrictor response and exhibit dilation.
These arteries are namely the cerebral, the coronary and the
hepatic artery. After hemorrhage the fractional distribution
of cardiac output is progressively increased to brain, heart
and hepatic arterial vascular bed at the expense of other
organs like skin, spleen, pancreas, bones, etc. The hepatic
artery vascular bed is the only one that shows significant
vasodilation at different levels of hemorrhage (Forsyth· et
al., 1970: Slater et al., 1973; Bellamy et al., 1984: Kaihara
et al., 1969: Gerkens et al., 1982). Adenosine has been
proposed as a metabolic regulator of coronary (Berne, 1963;
Thompson et al., 1980) and cerebral blood flow (Berne, 1985)
during hypotension and hypoxia. However such regulation has
not been confirmed physiologically. Could it be possible that
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adenosine is the universal blood flow regulator of these three
particular arteries? Such a hypothesis needs .to be tested and
fUlly evaluated.
By exclusion it seems that the dilator washout hypothesis
is the only hypothesis that can explain the mechanism of the
hepatic arterial buffer response without major objections.
1.6 HEPATIC ARTERIAL PRESSURE-FLOW AUTOREGULATION
It has been mentioned above that the hepatic arterial
conductance changes in response to variation in portal blood
flow (i. e. the hepatic arterial buffer response) in a way to
keep total hepatic blood flow steady. Regardless of portal
flow, can the hepatic artery change its own conductance in
response to changes in its perfusion pressure? Over the
years, many studies have been carried out on the effects of
changes in hepatic arterial pressure on hepatic arterial flow.
If no active changes in the vascular bed occur, a graph of
flow against pressure is linear or convex to the pressure
axis. A graph that is concave to the pressure axis indicates
an active response of the resistance vessels, and such a
mechanism tends to maintain blood flow and capillary pressure
constant When changes occur in arterial pressure. This
mechanism is referred to as hepatic arterial autoregulation.
The term autoregUlation has previously been used loosely to
describe two different situations, the change in hepatic
arterial resistance induced by a change in the portal flow and
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the change in hepatic arterial resistance in response to a
change in its perfusion pressure. In the first case, and as
it has been described in section 1.5, the term hepatic
arterial buffer response (HABR) was coined. The term
"autoregulation" will be used in this thesis to describe the
ability of the hepatic artery to maintain a relatively
constant flow in the face of changes in its perfusion
pressure, independent of the portal flow.
The existence of pressure-flow autoregulation in the
hepatic arterial bed is a controversial issue. Some studies
have demonstrated autoregulation (Andrews, 1958; Condon,
Chapmanet al., 1962; Greenway etal., 1967; Takeuchi et al.,
1966; Torrance, 1961), although its capacity may be small and
not seen in all experiments (Hanson, 1973; Hanson and Johnson,
1966). Other studies have indicated the absence of
autoregulation in the hepatic arterial bed, with the hepatic
arterial resistance either remaining constant or decreasing
with increasing arterial pressure (Richardson and withrington,
1978; Shoemaker, 1964). This controversy cannot be explained
on the basis of the experimental design or the state of
innervation of the liver.
The mechanism behind hepatic arterial autoregulation was
believed to be a myogenic one (Ha.nson, 1973; Hanson and
Johnson, 1966). The ability of papaverine, a potent direct
smooth muscle relaxant, to abolish hepatic arterial
autoregulation was considered as support for the myogenic
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hypothesis (Hanson, 1973). However, a potent vascular dilator
like papaverine can mask the effect of locally produced
vasodilators as well. Therefore, papaverine-induced
inhibition of autoregulation cannot differentiate mechanisms.
The previous information led us to the conclusion that the
mechanism behind hepatic arterial autoregulation is still
unclear.
1.7 THE OBJECTIVES OF THIS RESEARCH WORK
It is evident from the above introduction that the
hepatic artery plays a central and fundamental role in liver
function and thence body homeostasis as a whole. However,
major unsolved questions remain. The hepatic arterial buffer
response has been noted by many researchers, nevertheless, no
method to quantitate this buffering capacity has been
suggested. Therefore, the first aim of this research work was
to propose a method to quantitate the hepatic arterial buffer
response and to test whether the buffering capacity is
constant, regardless of the change in portal blood flow, or if
it is a variable one. The second objective of this research
work was to test the dilator washout hypothesis and to
determine if adenosine is the dilator responsible for the
mechanism of the hepatic arterial buffer response. The third
goal of this work was to confirm or deny the existence of
hepatic arterial pressure- flow autoregulation and to find the
best method to evaluate autoregulation and whether the present
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controversy reqardinq the existence of autorequlationcan be
accounted for by the methods o·f evaluation previously used.
If autorequlation is present, the· fourth objective was to
determine the mechanism of autorequlation and whether it can
be explained by the adenosine washout theory, i.e. has the
hepatic arterial flow, like the po_rtal flow, access to wash
out adenosine?
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2. METHODS
2. 1 SURGICAL P~PARATION
Twoserie$ of experiments have been conducted, one to
test the quantitation and the mechanism of the hepatic
arterial buffer response, the second to test the hepatic
arterial pressure-flow relationship and its mechanism. The
surgical preparation was basically the same in both series
with some minor modifications to suit the objectives of each
series.
Cats .of 'either sex were anesthetized with sodium
pentobarbital, 32.5mg/Kg body weight (Somnotol M.T.C.
Pharmaceuticals) given intraperitoneally. The level of
anesthesia was maintained by supplementary doses of 6mg
intravenously when corneal or swallowing reflex seemed to
recover. The body temperature was maintained at 37.SoC by use
of a rectal probe and a thermal controlled unit (Yellow
Springs Instruments, model 72) operating heating tapes in the
surgical table. The cats were fasted overnight with free
access to drinking water.
A polyethylene cannula (PE90) was placed in the brachial
vein for administration of anesthetic and fluids as required.
The plasma replacement solution was composed of Ringer's
solution and 10% Gentran 40 (Dextran 40) along with 5%
Dextrose in the ratio of 1:1. This solution was maintained at
370 C by using a water bath. Another cannula was placed in the
right femoral artery to monitor the systemic arterial blood
pressure. After laparotomy and splenectomy, the celiac artery
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and its branch:es (i.e. the common hepatic artery, splenic
artery, gastric artery, etc. ) and the superior mesenteric
artery were identified. Two electromagnetic flowprobes were
placed to measure hepatic arterial blood flow (HAF) and
superior mesenteric arterial blood flow (SMAF). Figure 6
shows the vascular preparation used. The hepatic arterial
probe (Carolina Medical'Electronics EP406) was placed on the
celiac artery and all flow in the celiac artery was directed
into the hepatic artery by 'ligating all branches of the celiac
artery as well as the gastroduodenal artery. The
gastroduodenal artery. and the splenic artery were cannulated
to allow for close intrahepatic arterial infusion of drugs
through the former and monitoring of hepatic arterial
perfusion pressure via the latter.
A micrometer-controlled screw clamp was placed around the
celiac artery distal to the flowprobe to control flow and
pressure within the hepatic artery. The second flowprobe
(Carolina Medical Electronics EP408) was placed on the
superior mesenteric artery (SMA). In this preparation, the
SMA flow is synonymous with portal blood flow as all other
inlet arteries that supply the portal vein (i.e. inferior
mesenteric artery, gastric artery, gastroduodenal artery, and
splenic artery) were ligated. In the autoregulation series,
an inflatable vascular occluder on the SMA was used, distal to
the flowprobe to determine the zero baseline and to initiate
the hepatic arterial buffer response (HABR). Inthe
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Fig. 6 Schematic description of the surgical preparation.
Portal flow to liver is made equal to superior mesenteric
arterial flow by removal of spleen, occlusion of
gastroduodenal artery, inferior mesenteric artery and gastric
artery. See text for calibration procedure. A, artery; SMAP,
superior mesenteric arterial pressure. (Lautt et al., 1985).
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quantitation s.eries, on the other hand, the inflatable
vascular occluder on the SMA was replaced by another
micrometer-controlled screw clamp to allow stepwise occlusion
of the superior mesenteric arterial blood flow (SMAl).
This methodology allows measurements of blood flows in
the only arteries left perfusing the liver. All blood
entering the portal vessel must derive from the superior
mesenteric artery. The anastomotic connections of the SMA
provide -adequate blood flow to -the regions normally supplied
by the gastric and inferior mesenteric arteries as jUdged by
lack of gross evidence of ischemic regions and the presence of
microspheres in all tissues when injected via the ascending
aorta (19 observations) (for methodology of injection and
results see section 2.3 and Appendix B). On three occasions,
postmortum evaluation of the surgical preparation was
conducted. The thoracic aorta and the superior mesenteric
artery were ligated and cannulated. Pink latex was injected
through the superior mesenteric arterial line to visualize the
area of its blood supply. Blue latex was injected in the
descending thoracic aortic line. The blue latex filled the
abdominal aorta and the celiac artery and all their
tributaries. The cat carcass was stored in the cold room and
macroscopic examination was conducted 24 hours later. Latex-
injected dissections revealed no blue latex (non-SMA
tributaries) in the splanchnic organs except at the cardia of
the stomach and the lower end of the rectum. This finding has
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confirmed a lack of non-SMA·inlets to the splanchnie·organs in
our preparation.
A catheter was advanced from the small vein that drains
the cecum into the portal vein, the tip of which was about 2cm
back from the hilum of the liver, to allow for continuous
portal venous pressure measurement. Another catheter was
advanced from one of the splenic veins into the portal vein.
The tip of this catheter was 2.5-3cmback from the hilum of
the liver to allow for close intrahepatic portal infusion of
drugs with adequate mixing in the portal blood (Lautt et al.,
1984).
In a group of cats from the autoregulation series, a
snare was placed around the abdominal aorta below the kidneys.
The occlusion of the abdominal aorta at this position will
increase the peripheral resistance and elevate systemic blood
pressure. Since occlusion of the aorta below the kidneys
interferes with systemic pressure recording from the femoral
arterial line, in this group of cats the superior mesenteric
arterial pressure was monitored via a cannula placed in the
artery supplying the cecum. Gould and Statham pressure
transducers were used for measuring blood pressure; blood
pressure and flows were recorded on a Sensor Medics RM611
dynograph.
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2.2 CALIBRATION
Prior to the commencement of experiments pressure
transducers were calibrated. A glass manometer, U in shape,
partially filled with mercury or water was used to calibrate
for arterial and venous pressure respectively. One of the two
open limbs of the manometer was connected by a rubber tube to
the pressure transducer via a three-way stopcock. With the
occlusion of the connection between the transducer and the
manometer,.air .was pumped (by a syringe). through the stopcock'
to the manometer to create a column difference of mercury
equal to lOOmm (lOcm). Then the connection between the
manometer and the transducer was reopened at the stopcock
site. The sig-nal recorded by the dynograph recording pen was
then adjusted, with the use of special amplifiers, to make· a
20mm deflection from the preset zero baseline. Hence, every
Imm deflection on the dynograph record is equivalent to 5mmHg
pressure. This transducer was allocated to measure the
arterial blood pressure. Technically, the same procedure was
used to calibrate the transducer used to 'measure venous
pressure with some changes. The mercury was replaced by water
and the column difference was set to be 13. 6cm (equal to
lOmmHg) • Therefore, Imm deflection from the venous pressure
t.ransducer is equal to 0 .5mmHg • Both arterial and venous
pressure transducers were set on the surgical table at t.he
level of the inferior vena cava of the animal. Pressure
transducer calibrat.ion was rechecked every 6-8 weeks.
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The calibration of each electromagnetic flowprobe was
conducted in situ at. the conclusion of each experiment. The
calibration procedure of the hepatic artery was facilitated by
the application of a thread placed around the common hepatic
artery during the initial surgery. This thread was pUlled to
give a zero flow at the conclusion of the surgical setup.
This zero flow must match the zero flow obtained using the
clamp on the celiac artery. This testis done at the end of
each experiment as well. Then ,the polarity on the flowmeter
(Carolina Medical Electronics, electromagnetic blood
flowmeter, Model 501) was reversed and the animal's own blood
was pumped at a constant rate, using a Harvard infusion pump,
backward through the celiac artery using the catheter
cannulated through the splenic branch of the celiac artery
(the catheter that was used to monitor hepatic arterial
pressure). The advantages of this system are that calibration
can be done in situ without need to open the abdomen, and the
constant infusion rate (38m1 per minute, from SOml syringe)
allows for an absolutely stable and precise measurement to be
made from the flow trace with a precisely known flow rate.
The approach to the SMA calibration was traditional. The
abdomen was. reopened at the conclusion of the hepatic artery
calibration, and the SMA was cannulated distal to the
flowprobe. The blood was then infused backward (i.e. toward
the aorta) with reversed flowmeter polarity. The reopening of
the abdomen and the perturbation of the flowprobe makes the
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calibration les~ ideal eompare<i.to that of the hepatic artery.
The blood used for calibration was obtained by withdrawing' 50-
80ml of blood from the cat at the end of the experiment. The
blood was kept in a beaker with heparin (1000-3000 IU) to
prevent coagulation.
2.3 THE RADIOACTIVE MICROSPHERE TECHNIQUE
The microsphere technique was used in few animals (n=5)
to validate the use of the superior mesenteric arterial flow
(SMAF) as an index of portal blood flow. This technique
allows the measurement of regional blood flow changes in
conscious and unconscious preparations without inducing
significant hemodynamic alterations. The principle behind
this technique is that proper mixing of plastic microspheres
with the blood stream leads to even distribution of these
microspheres within the blood stream, and ends in their
permanent entrapment in the arterioles or capillaries (i.e.
microembolization) on the first circulation after injection.
Hence, microsphere distribution would approximate red blood
cell distribution and the percentage of microspheres entraped
ina tissue would be equal to the percentage of cardiac output
supply of blood flow to that tissue. The proportion of
distribution of microspheres can be obtained by substituting
the number of microspheres by its corresponding radioactivity
since the nUmber of entraped microspheres is directly
proportional to the amount of radioactivity they emit (Lebrec
53
and Blanchet, 1~B5; Heymann et al., 1977). It is inconvenient
to give the full description of the. radioactive microsphere
technique in this thesis since the pilot study, in which it
was used, was designed to validate a technical point in our
surgical preparation. The full description of the technique
was dealt with elsewhere (Heymann et al., 1977). Briefly, the
surgical preparation was identical to that used in the
quantitation and autoregulation series with minor
modifications. The right carotid artery was· cannulated with a
PE190 cannula. The cannula was advanced retrograde B.5cm
toward the arch of the aorta. The slightly precurved tip -of
this cannula was placed in the arch of the aorta facing the
aortic valve of the left ventricle. This cannula was used to
administer the radioactive-labelled microspheres. Postmortum
examination of each cat was performed to check the position of
the carotid cannula. Then the kidneys, lungs, liver,
pancreas, stomach, small intestine, large intestine, rectum
and omentum were taken and their weight (in grams) and
radioactivity were measured.
Two kinds of radionuclide-labelled microspheres were used
in this study. They were Cobalt 57 (57Co, New England
Nuclear, Cat. No. NEM 012A, Lot. No. Co1569, size 16.4 + O.2u)
with a specific activity of 11.52 mci/g and a half life of 271
days, and Tin 113 (113Sn ,New England Nuclear, Cat. No. NEM
062A, Lot. No. SN1568, size 16.5 ± O.lu) with a specific
activity of 12.11 mCi/g and a half life of 115 days. The
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approximate number of microspheres administered in each
experiment was 500,000 microspheres of each kind. All
radioactivities were counted by using LKB WALLAC 1282
Compugamma (Universal Gammacounter) • Each batch of
microspheres was placed inside a glass injector (Figure 7).
The microsphere suspension was mixed (by vortex) for. 1 min
before the injection of microspheres into the body of the cat
with 5ml warm, normal saline (37oC) through the carotid line.
The injection of microsphereswas manual over a period of 15-
25 seconds along with continuous shaking of the injector. A
reference blood sample was withdrawn from the femoral arterial
cannula at a rate of 1.94ml/min using a Harvard infusion-
withdrawal pump. The withdrawal started 15-20 seconds before
the administration· of microspheres and lasted 1.5 minutes
after the end of' microsphere infusion. Tissue samples and
reference blood samples were counted all on the same day. The
spill-over correction of 57Co and 113Sn activity as well as
decay correction were made automatically by the computerized
unit attached to the gammacounter.
The protocol of this microsphere stUdy was to administer
the first batch of microspheres (control) to be followed, 5-10
minutes later, by occlusion of the SMA and administration of
the second batch of microspheres. The detection of any
radioactivity, from the second batch of microspheres , in the
splanchnic organs would suggest the existence of an arterial
contribution to portal flow other than the SMA flow.
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Fig. 7 Diagramatic illustrations of the glass vials used to
inject the microspheres. The size used depends on animal size
and hence the number of microspheres to be injected, the
flushing volume and the size of the gamma-counter vial.
(Heymann et al., 1977).
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Calculation of regional blood flow to any orqan was made
accordinq to this formula:
Organ flow (ml/min) =
organ radioactivity x reference sample withdrawal rate
reference sample radioactivity
The radioactivity of an organ should be of .the same range
of nuclide activity as the reference blood sample. The same
formula was used to calculate cardiac output (CO) with the
substitution of the organ activity by the total activity
administered to the animal. Decay correction calculation was
made according to the formula:
Ao = A x 2~
Where Ao is the original radioactivity and A is the
corrected radioactivity; H is the isotope half life and h is
the time elapsed between microsphere administration and tissue
samples counting. Portal blood flow was calculated from the
sum of flows to the splanchnic organs. These organs are the
stomach, small and large intestine, rectum, pancreas and the
omentum. The contribution of these organs to portal flow was
confirmed by retrograde infusion of blue-latex in the portal
vein on three occasions. The pattern of distribution of the
latex indicated that portal vein tributaries arise between the
lower end of the esophagus (about 2cm above the cardia of the
stomach) and the last 2-3cm of the rectum inclUding the
pancreas and the omentum.
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The lungs. were examined for the presence or absence of
radioactivity to test for the existence of microsphere
shunting from the arterial to the venous circulation. Equal
renal flow for each kidney was an index of proper mixing of
microspheres with the blood stream.
2.4 SOLUTIONS AND CHEMICALS
Adenosine was dissolved in warm Ringer's solution and
,infused .at a rate of O.206ml/min '(O.4mg.min-1 .Kg-l). The
infusion was through the portal vein. Three adenosine
receptor blockers have been used. l-Methyl-3-isobutyl-
xanthine (MIX, Sigma Chemical Company, No.1-5879) and 8-
phenyltheophylline (8-PT, Research Biochemicals Inc., Cat. No.
A-12) each was dissolved in warmed NaCl (O.lM) solution at a
pH of 12.27 adjusted with lN NaOH. MIX was used in the
quantitation series and was infused at a rate of o.34ml/min
(O.lmq.min-l.Kq-l). The third adenosine receptor blocker S(p-
sUlfophenyl) theophylline (S-SPT, Research Biochemicals Inc.,
Cat. No. A-13) is water soluble and was dissolved in warm
Ringer's solution. The two adenosine receptor blockers, 8-PT
and 8-SPT, were used in the autoregulation series and were
given in bolus doses and not as continuous infusion as with
MIX. The route of administration of the three adenosine
receptor blockers was into the hepatic artery to get the
highest chance of contact between the blockers and adenosine
receptors in the hepatic arterial vascular bed.
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In some. experiments of the autoregulation series
norepinephrine (Sigma chemical Co. ,L-Arterenol HCl, No. A-
7381) and isoproterenol (Sigma Chemical Co., L-isoproterenol
HCl, No. I-6S04) were infused intraportally at a rate of
0.lug.min-1 .Kg-1 body weight and 0.2ug.min-1 .Kg-1 body weight
respectively. Each was dissolved in Ringer solution and
infused at a rate of 0.136ml/min. Norepinephrine was prepared
from stock solution containing Img/ml norepinephrine (NE).
Norepinephrine comes from the supplier as Salts of NE-
bitartrate (mol. wt. = 337.3) or NE-HCl (mol. wt. = 205.7).
The actual molecular weight of norepinephrine itself is 169.2.
Therefore, to make 1mg HE/ml stock solution, 1.22mg of NE-Hel
should be dissolved in 1ml of normal saline or distilled
water. For catecholamines there is a danger of oxidation
during storage, so 10mg of ascorbic acid (a stabilizer) was
added to each 50ml of the stock solution before the volume is
reached. Then the stock solution of norepinephrine is divided
into small vials and stored frozen in a deep freeze (-SoC). To
calculate the concentration and volume of NE solution required
for each experiment these general formulas were used:
A) dose required (mg.min- l .Kg-1)/pump infusion rate (ml.min-l )
= Xmg.ml-1 .Kg-1 = concentration required expressed per
Kg body weight.
B) stock conc./conc. required = dilution factor.
C) stock volume to be diluted = mls of NE-solution sufficient
for the exp./dilution factor.
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2.6 AUTOREGULATION OF HEPATIC ARTERIAL BLOOD FLOW
On three occasions, stepwise pressure-flow curves
(similar to that seen in Figure 16) were compared with curves
obtained by a series of independent pressure decreases with
stabilization periods between responses (Figure 8). The
curves appeared the same and $0 all tests used the more rapid
and convenient method of stepwise pressure changes. Control
responses were obtained to adenosine infusion, the hepatic
arterial buffer response, and a pressure-flow curve. The 8-PT
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Fig. 8 Non-step~ise pressure-flow record with control base
line intervals ~n between responses followed by control
hepatic arterial buffer response during complete occlusion of
superior mesenteric arterial flow (SMAF). Note that SMAF
shows no reciprocal response to changes in hepatic arterial
flow.
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bolus dose was given in a progressively increasing fashion
starting with 0 .lmg. Kg-1 body weight t.o a maximum value of
16mg.Kg-1 body weight (n=5). The bolus dose was administered
over one minute to be followed, after baseline stabilization,
by adenosine infusion. Once the response to the externally
administered adenosine was blocked, the stepwise reduction in
the hepatic arterial pressure and occlusion of the portal flow
(to induce the hepatic arterial buffer response) were
performeq.
In another group of cats (n=6) the systemic blood
pressure was temporarily elevated, prior to the commencement
of the experiment, by occluding the aorta below the kidneys.
This allowed the pressure-flow curve to be obtained over a
larger pressure range. This procedure was previously shown to
produce elevation in arterial pressure with no effect on
stroke volume, cardiac output or myocardial Shortening
(stokland et al., 1981). In this group two kinds of adenosine
receptor blockers were used, 8-PT (n=3) and S-SPT (n=3).
Pressure-flow curves and the buffer response were also
determined during continuous norepinephrine infusion (n=5) .at
a rate of O 1 . -1 K -1. ug.mJ.n . g body weight or isoproterenol
infusion (n=4) at a rate of O.2ug.min-1 .Kg-1 body weight
intraporta1ly.
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2.7 MATHEMATIC~L.ANDSTATISTICAL CALCULATIONS
Three means have ·been used to quantitate the hepatic
arterial buffer response: the absolute rise in hepatic
arterial conductance (HAC), the percent change in hepatic
arterial conductance (%!J. HAC), and the bUfferingcapacity •
The buffering capacity was calculated from the absolute . rise
in hepatic arterial flow divided by the absolute decrease in
SMA flow (i.e. portal flow). This value was expressed as
percent where 100% would indicate· a complete bUffering of
reduced portal flow by the hepatic artery.
Therefore:
Hepatic Arterial =
Buffer Capacity
change in HAF x 100%
opposite chanqe in portal (SMA) flow
The hepatic arterial autoregulation has been quantitated
according to three indices. 1) The percent change in hepatic
arterial resistance(% IJ.. BAR) over the autoregulatory pressure
range. 2) The autoregulatory index (ARI) over the same
autoregulatory range (Semple and DeWardener, 1959). The ARI
was calculated according to this formula:
ARI = CHAFc - HAFsl/HAFc(HAPc - HAPs)/HAPc
HAF and HAP are hepatic arterial flow and pressure; c
signifies the control or initial state ands indicates values
measured at the shoulder of the pressure-flow curve. It is
evident from the ARI formula that ARI is equal to the percent
chanqe in hepatic arterial flow for each unit percent change
in the hepatic arterial pressure. If a unit % change HAP is
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accompanied by. a unit % change HAF, then ARI value will be
equal to one. ARI values of one or more indicate no active
change in the vascular bed to autoregulate blood flow. On the
contrary it means that the resistance of that vascular bed is
either constant or decreasing with the increase in the
pressure gradient aCl;"oss that vascular bed. ARI values of
less than one mean an increase in resistance with the increase
in pressure gradient across that vascular bed, which indicates
the existence of pressure-flow autoregulation in that vascular
bed. 3) A new index, the slope index, which is basically a
test of linearity of the pressure-flow curve (see Figure 18
for description). In addition, where a calculation required
use of a pressure gradient across the hepatic artery, we have
calculated the arterial pressure gradient (in some
experiments) in three ways: (a) absolute arterial pressure
(equivalent to studies that assume zero hepatic venous
pressure); (b) absolute arterial pressure minus sinusoidal
pressure (portal venous pressure - see Discussion Section
4.6) i (c) absolute arterial pressure minus critical closing
pressure.
discussion.
For comparison of the various methods see the
Hepatic arterial resistance is calculated from arterial
pressure gradient across the hepatic artery divided by
arterial blood flow. i.e.
HAR = HAP Gradient mmHg.ml-1.min.Kg
HAF
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Unless mentioned otherwise, the gradient will be calculated as
HAP minus sinusoidal (portal) pressure. Conductance, used in
calculations too, is the inverse of resistance.
HAC = __-=1__
HAR
= HAF
HAP Gradient
For the purpose of pooling different pressure-flow curves
in the autoregulation series, the curves from each experiment
were normalized. Normalization was essential since raw data
were highly variable within and between experiments. The
autoregulation series,as described above, was divided into
raised and unraised pressure subseries. The HAF at HAP of
120mmHg (in the raised pressure sUbseries) and at HAP of
100mmHg (in the unraised pressure subseries) were chosen as
control and were considered to be 100%. The remaining points
on the curve were adjusted accordingly. Then the mean of the
normalized HAF was obtained at 10mmHg intervals (Figure 17).
Comparison of various responses was made using paired t-
test and two way analysis of variance. The paired t-test was
used to determine whether the difference between two related
data points was significantly different from zero. Both raw
and normalized data were tested since each of the groups of
related data points are believed to be normally distributed
(i.e. the differences between paired observations are also
normally distributed). Means of mUltiple response data points
(such as raw or normalized data points on a curve) were
compared by using two-way analysis of variance since all
responses appeared once in each cat.
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The change was
considered sign~ficant when p<O.OS. Changes in conductance or
resistance were expressed as percent of basal level. Slopes
of each hepatic arterial pressure-flow curve (above and below
the shoulder - see Figure 18) were calculated from the raw
data points by the use of regression analysis. Data were
expressed throughout as means and standard errors.
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3. RESULTS
3 • 1 THE QUANTI';['ATION AND MECHANISM OF THE· HEPATIC ABTER:J;AL
BUFFER RESPONSE
3.1.1. The Quantitation of the HABR
To quantitate the HABR, the superior mesenteric arterial
flow (which is equivalent to portal flow in our preparation)
was reduced to 20, 40, 60, SO, and 100% of its control level
using the micrometer screwclamp. The degree of reduction was
calculated instantly depending on the flowmeter display
recording. The method used 'to initiate variable degrees of
HABR is clearly demonstrated in Figure 9. After each HABR the
hepatic and superior mesenteric arterial flow were allowed to
return to control levels to ensure validity of the results.
The hepatic arterial buffer response was quantitated by
the use of three mathematical expressions: the response
change in hepatic arterial flow (HAF) for each unit change in
superior mesenteric arterial flow (SMAF) expressed as percent
[(~HAF/~SMAF) x 100%], the percent change in hepatic arterial
conductance (% Ii HAC) and the absolute change in HAC. The
first method of calculation of the HABR capacity is more
appropriate to quantitate the buffer response since it
reflects the stimulus-response relationship between the
superior mesenteric artery (SMA) and the hepatic artery (RA).
The other two methods are less appropriate to express the
capacity of the HABR as the SMAF is not included. The first
method is used in this thesis to calculate the bUffering
capacity wherever required. The other two methods were used
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Fig. 9 Record of the relationship between hepatic arterial
buffer response and stepwise decrease in superior mesenteric
arterial blood flow.
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to compare and confirm results obtained by the application of
the first method.
The relationship between the capacity of HABR and the
changes in SMAF is shown in Figure 10. The capacity of the
HABR increased with the decrease in SMAF to reach its highest
level of 24.24 ± 2.86 at 60% decrease in SMAF. Further
decrease in SMAF did not increase the bUffering capacity, it
rather decreased it. The bUffering capacity at 100% decrease
in SMAF ·(17.69.± 3.45)w.as not significantly different·from
that of 20% reduction in SMAF (15.14 ± 2.66). However, the
peak bUffering capacity obtained at 60% decrease in SMAF was
not statistically significantly different from that reached at
40 and 80% decrease in SMAF.
The calculated bUffering capacity mentioned above was
obtained after the correction of the hepatic arterial pressure
(HAP) to be equal to its control value prior to the occlusion
of the superior mesenteric artery (Refer to Figure 3, stage
C) . However, in normal physiological situations hepatic
arterial flow changes coexist with changes in hepatic arterial
pressure as well, i.e. the HAP is not constant. Therefore,
the data were recalculated to obtain the bUffering capacity of
the hepatic artery during uncontrolled HAP (Figure 3, stage
B). The HABR capacity under uncontrolled HAP was found to be
constant at any degree of decrease in SMAF with a mean value
of 30.30 ± 2.79. The comparison between the buffering
capacities of the HAP-controlled and uncontrolled situations
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change in superior mesenteric arterial flow (= portal flow).
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are clearly il~ustrated in Figure 11.. The HAP-uncontrolled
data showed a tendency for the bUffering capacity to decline
slightly after 60% decrease in SMAF, however, that decrease
was not significant statistically.
To quantitate the bUffering capacity of the HABR using a
different criterion, the percent change in hepatic arterial
conductance (% t::. HAC) was used (Figure 12). The change in
hepatic arterial conductance increased sharply from a value of
4.80 ± 0.96% (at 20% decrease in SMAF) to a value of 23.01 ±
1.86% (at 60% decrease in SMAF) , then reached a maximum value
of 28.68 + 3.59% at 100% decrease in SMAF (i.e. complete
occlusion of the SMA). The %L\HAC reached at 60% decrease in
SMAF was significantly different (P<O.Ol) from that reached at
100% reduction, but was not different from that reached at 80%
reduction in SMAF. The %t::.HAC values attained at 80% and 100%
decrease in SMAF were not significantly different from each
other.
To demonstrate the effect of HAP on %t::. HAC , the data were
recalculated to obtain HAC during uncorrected HAP. The
hepatic artery showed some degree of autoregulation since HAC
at higher HAP was less than that at lower HAP. In other
words, HAC calculated during phase C (Figure 3) was higher
than that calculated from phase B. The maximum difference
between HAP-controlled and uncontrolled %AHAC was reached at
80% decrease in SMAF (HAP-controlled %t::. HAC = 25.97 ± 2.31%;
HAP-uncontrolled %t::.HAC = 20.29 + 2.21%). The difference was
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highly signifi.cant statistically (P<O.Ol). At complete
occlusion of the SMA the difference decreased and became not
significant statistically.
The actual change in HAC was used as a third criterion to
quantitate the bUffering capacity of the HABR. The basal
conductance of the hepatic artery in the quantitationseries
was 0.196 + 0.013 ml.min-1.Kg-l.mmHg-1 (35 observations). The
HAC increased steadily, with the decrease in SMAF, to a peak
value of 0.254 ± 0.043 ml.min-1 .Kg-l.mmHg-1 at 80% decrease in
SMAF (Figure 13). However, HAC peak values reached at 60, 80
and 100% decrease in SMAF were not significantly different
from each other. Again the comparison between HAC during HAP-
controlled and uncontrolled phases revealed a maximum
difference at SO% drop in SMAF, however, the difference was
not statistically significant.
To test whether the highest HABR capacity was because of
full dilation of the hepatic artery, a paired-comparison was
made between the highest (peak) HAC reached during HABR and
the HAC during the intraportal venous infusion of adenosine
(0.4 - 1mg.Kg-1. min-1 ) (N=7). Adenosine infusion dilated the
HA and elevated HAC to a mean value of 0.299 + 0.045 ml.min-1
.Kg-1. mmHg-l which is significantly higher (P<0.05) than that
(0.240 ± 0.042 ml.min-1 .Kg-1.mmHg-1 ) reached during peak
buffer. Therefore, it was concluded that peak HABR was not
because of full dilation of the hepatic artery since it can
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arterial
superior
dilate more in response to the infusion of a vasodilator such
as adenosine.
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adenosine and hepatic arterial buffer response (HABR).
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hepatic artery under MIX effect should be testedwith·another
dilator, other than adenosine, to prove or disprove that it
was maximally dilated and that it could still react to other
vasoactive substances. Since such a test was not conducted in
this series, the data cannot exclude the possibility that the
hepatic artery was maximally or submaximally dilated. However,
there was more than one reason to suggest that the inhibition
of the HABR and the dilator response to infused adenosine were
related to the blockade of adenosine receptors. The
discussion of these reasons will be presented later. The non-
selective blockade property of MIX makes it essential to use
other more selective adenosine receptor blockers that do not
affect the basal conductance of the hepatic artery. The
adenosine receptor blockers 8-PT and 8-SPT were used, for that
reason, in the sUbsequent experiments.
MIX was found to be a labile adenosine receptor blocker.
Responses to infused adenosine return to normal within 5-10
minutes after cessation of the infusion of MIX despite the
well maintained systemic effects.
MIX seems to counteract the effect of anesthesia. The
anesthetic level of the animal wears off during MIX infusion.
This effect was manifested as recurrence of brisk swallowing
and corneal reflex. The respiration rate increased and became
shallow. with periodic gasps. Spontaneous flickering of the
ears was not uncommon. On the other hand, it was inconvenient
to give the. animal supplementary doses of anesthesia because
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of .• its lower b+ood pressure ·due to the MIX-induced systemic
vasodilation. Therefore, MIX is not a convenient adenosine
blocker to be used in the··whole animal preparation.
3.2 PRESSURE-FLOW. AUTOREGULATION.OE.nR! HEPATIC ARTERY
Any cat that did not show dilation of the hepatic artery
to infused adenosine was. excluded from this study. A response
to adenosine and a functional buffer response were used to
assess pharmacological blockade of adenosine receptors.
Previous unpublished observations, by us, were that if the
hepatic artery does not respond to adenosine, it does not show
dilation to reduced portal floW (i.e.HABR). In. this series,
about 50% of cats were eliminated from this stUdy according to
this inclusion criterion,because of lack of response to the
test dose of adenosine. Every cat that showed a response to
adenosine also showed a buffer response and hepatic arterial
autoregulation. Three cats that did not show response to
adenosine were tested and found not to show autoregulation; no
others were similarly tested.
One group of cats was studied under normal blood pressure
conditions (unraised-pressure series, N=5) , while a second
group was studied in the same way using aortic occlusion below
the kidneys to elevate systemic pressure (raised-pressure
series, N=6). The evaluation and comparison of the capacity
of autoregulation, according to the three indices used, was
entirely based on absolute data. However, visual comparison
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between a group of pressure-flow curves cannot be done without
standardization of these curves. Curves vary in the degree of
curvature, the position of the curve on the pressure axis, the
location of the shoulder and the initial flow varied from
curve to curve within the same experiment and between the
experiments. To standardize a group of curves, the highest
shared arterial pressure point is determined. The hepatic
arterial flow of each curve, at that common pressure point, is
considered as. 100% for that particular curve. The rest of the
flow points on the curve will be expressed as percent of the
~OO% (control) point of that curve. In the unraised pressure
group, pressure-flow curves were standardized from a control
blood pressure of 100mmHq; the raised pressure group was
standardized from 120mmHg. Each individual pressure-flow
curve was sigmoid in shape and concave to the pressure axis
(control curve of Figure 15). However, the process of
standardization and pooling of different curves underestimated
the degree of concavity of each individual curve.
To obtain a pressure-flow curve, HAP was reduced in
stepwise fashion by the use of the micrometer-controlled
screwclamp around the hepatic artery as mentioned above (in
the methods). In the raised-pressure group the stepwise
reduction of HAP was preceded by the occlusion of the aorta
below the kidney to raise the systemic blood pressure. Figure
16 shows both the pressure-flow responses and effect of aortic
occlusion on HAP in one cat from the raised pressure series.
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Fig. 15 Relationship of hepatic arterial perfusion pressure
(HAP) to hepatic arterial flow (HAF) presented as percent of
control flow, before and after administration of two bolus
doses of adenosine blocker in one cat. Histograms represent
effect of adenosine blocker on hepatic arterial buffer
response (HABR) expressed as rise in HAF divided by decrease
in portal flow (XIOO%) and adenosine response expressed as
percent rise in vaSCUlar conductance. Note that the first
dose produced partial antagonism of the HABR, the dilator
effect of exogenous adenosine and autoregulation.
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Fig. 16 Trace taken from one cat to illustrate effect of
aortic occlusion on splanchnic hemodynamics followed by
stepwise reduction in hepatic arterial pressure (HAP) and flow
(HAF). PVP, portal venous pressure; SMAP, superior mesenteric
arterial pressure; SMAF, superior mesenteric arterial flow.
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The mean rise in systemic blood pressure after lower aOl:."tic
occlusion was similar in the control state (13.1 +. 4.0mmHg)
and in the adenosine receptor blocked state (13.8 ± 3. 5nunHg) •
The stepwise reduction in hepatic arterial pressure and flow
was accompanied by a small rise in flow (3.5 ± 1.2ml/min per
Kg) of the superior mesenteric artery (portal flow) which was
similar in the adenosine blocked state (3.3 ± 1.3ml/min per
Kg). The aortic occlusion tended to cause mild constriction
(Table~) but did not cause statistically significant change
in basal conductance of the superior mesenteric artery or the
hepatic artery or in the critical closing pressure in the
control or blocked state. The mean critical closing pressure
(ccp) pooled from both groups was 11.5 ± 1.4mmHg and portal
pressure was 8.5 ± 0.6mmHg, significantly lower (P<0.02) than
ccp. The raised-pressure group was initiated in order to
provide a longer pressure-flow curve.
3.2.1 Assessment of <Adenosine Antagonism
The bolus blocking dose range used for 8-PT was 0.8-
16mg.Kg-l body weight and 4 - 16mg.Kg-1 body weight for 8-SPT.
The adenosine receptor blocker 8-PT was more potent and more
stable compared to 8-SPT. The blocking property of 8-PT could
be detected at a low dose of O.4mg.Kg-1. A supermaximal dose
of 16mg.Kg-l caused the hepatic artery to constrict and HAF to
drop to zero. The blocking effect of 8-PT was reversible and
lasted about 20-30 minutes. The water soluble adenosine
receptor blocker 8-SPT started to show its blocking property
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at a bolus dose of 2mg.Kg-1 in some preparations (range> 4-
8mg/Kg) • In others it failed to show any blocking property
even at a dose of 16mg.Kg-l, and therefore, it was substituted
by 8-PT. The blocking property of 8-SPT was reversible as
well and lasted for about 15-20 minutes. The two blockers did
not alter basal parameters as shown in Table 1. However, 8-PT
showed a tendency to vasoconstrict the hepatic artery. This
hepatic arterial vasoconstrict.ion was not significant
statist.ically. The blocker 8-SPrseemed·to have no vasoact.ive
property. The unraised pressure group received only 8-PT
(N=5). The blockers 8-SPT (n=3) and 8-PT (n=3) were used in
the raised pressure series and the data were pooled.
The adenosine antagonists 8-PT and a-SPT blocked the
hepatic arterial vasodilator response to intraportal infusion
of adenosine (Table 2) in both groups. similarly, the hepatic
arterial buffer response was significantly antagonized. Note
that aft.er t.esting these responses following blockade of
adenosine receptors, a final dose of adenosine was given to
assure that blockade had not worn off since we commonly see
potentiation of adenosine response immediately following
recovery from blockade. Lautt and Legare (1985) tested the
effect of 8-PT administration on isoproterenol. The
vasodilator response to iSioproterenol infusion was maintained,
and therefore, it was concluded that the blockade was
selective for adenosine and did not represent a det.erioration
of the preparation.
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TABLE 1 Values are means and standard errors measured before
and after administration of a blocking dose of 8-PT (n=3) or
8-SPT (n=3) in the group with raised blood pressure and 8-PT~
in the group with unraised pressure. HAF is hepatic arterial
flow; HAR is HA resistance; HAC is conductance; ccp is
critical closing pressure; PVP is portal venous pressure. HAR
and HAC are calculated using zero venous pressure to allow
comparison with previous autoregulation studies. Recalculated
HAR and HAC using the recommended procedure of HAP - PVP to
calculate perfusion pressure showed no change in these or
other statistical tests except that where a change from
control to blocked state was significant, the level of
significance was greater using HAP - PVP rather than HAP-
zero (see Table 2). No basal parameters were significantly
altered by the adenosine antagonists (paried-t test, n=6).
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TABLE 1
EFFECT OF ADENOSINE BLOCKERS ON BASAL PARAMETERS
RAISED PRESSURE GROUP
(N=6; HAP=120 mmHg)
HAF (ml.min-1 .Kg-1)
HAF as % of total liver flow
HAR (mmHg.ml-1.min.Kg)
-1 -1 -1HAC (ml.min .Kg .mmHg )
ccp (mmHg)
PVP (mmHg)
UNRAISED PRESSURE GROUP
(N=5; HAP=100 mmHg)
HAF (ml.min-1.Kg-1)
HAF as % of total liver flow
-1HAR (mmHg.ml .min.Kg)
HAC (ml.min-1.Kg-1.mmHg-1)
ccp (mmHg)
PVP (mmHg)
CONTROL
27.1 + 9.1
42.7 + 3.7
6.5 + 1.4
0.23 + 0.08
13.6 + 1.9
9.0 + 0.9
CONTROL
37.3 + 11.7
38.0 + 7.0
4.3 + 1.6
0.37 + 0.12
9.5 + 1.3
7.8 + 0.4
ADENOSINE BLOCKER
33.7 ± 12.2
47.6 + 5.7
5.6 + 1.3
0.28 + 0.10
14.6 + 1.9
9.8 + 0.6
ADENOSINE BLOCKER
22.3 + 5.0
30.3 ± 5.3
5.7±1.4
0.22 + 0.05
11.3 ± 1.1
8.6 + 0.4
TABLE 2 Effect of adenosine blockers in the unraised and
raised pressure groups on the response to infused adenosine,
on an intrinsic response previously shown to be adenosine
mediated. (HABR) and on indices of autoregulation. Effects of
adenosine infusion (0.4 mg/Rg per min, i. p. v.) are shown as
percent change in conductance and resistance. The hepatic
arterial buffer response (HABR) capacity is expressed as the
increase in arterial flow divided by the reduction in portal
flow as a percent. Indices of autoregulation are: ARI,
autoregulatory index calculated according to (Semple and
DeWardener, 1959) where zero venous pressure is assumed; %
change in hepatic arterial resistance seen when blood pressure
is decreased from control state (120 nunHg in raised pressure
group, 100 mmHg in unraised pressure. group) to shoulder of
pressure-flow curve (70 ± 6 mmHg); slope index is the slope of
the pressure-flow curve over the autoregulatory range divided
by the slope below the autoregulatory range (see Figure 18).
All responses were significantly impaired by adenosine
blockers (paired-t test; * = p<0.05; ** = p<O.Ol).
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TABLE 2
EFFECT OF ADENOSINE BLOCKERS ON INTRINSIC REGULATION OF THE HEPATIC ARTERY
RESPONSE TO EXOGENOUS ADENOSINE:
(%llHAC) UNRAISED PRESSURE GROUP
RAISED PRESSURE GROUP
RESPONSE TO EXOGENOUS ADENOSINE:
(%llHAR) UNRAISED PRESSURE GROUP
RAISED PRESSURE GROUP
CONTROL
41.5 + 9.0
57.0 + 15.4
-27.8 + 3.8
-33.3 + 5.8
ADENOSINE BLOCKER
5.8 + 2.1
5.5 + 1.8
-5.3 + 1.9
-5.3 + 1.7
P
**
**
**
**
RESPONSE MEDIATED BY ENDOGENOUS ADENOSINE:
(HABR) UNRAISED PRESSURE GROUP 27.7+ 5.7
RAISED PRESSURE GROUP 28.5 + 7.4
6.4 + 3.7
9.3 + 3.1
**
*
CALCULATED INDICES OF AUTOREGULATION:
ARI UNRAISED PRESSURE GROUP
RAISED PRESSURE GROUP
%llHAR UNRAISED PRESSURE GROUP
RAISED PRESSURE GROUP
0.86 + 0.06
0.88 ±. 0.05
-12.8 + 4.4
-14.4 + 2.0
1.11 + 0.06
*
1.19 + 0.04 **
0.2 + 3.8 *
-1.1 + 2.8 **
SLOPE INDEX
UNRAISED PRESSURE GROUP
RAISED PRESSURE GROUP
39.6 + 6.3
53.7 + 5.6
73.7 + 7.8
81.8 + 5.3
*
**
3.2.2 Antagonism of AutoreguJ,.ation
Figure 15 shows pressure-flow curves from one cat, where
tests were done a·fter partial and full blockade, standardized
by expressing blood flow at 100mmHg pressure as 100%. The
control curve shows the classic autoregulatory sigmoid curve,
concave to the pressure axis, intercepting the pressure axis
at a critical closing pressure above zero. The hepatic
arterial buffer response (HABR) is shown in the histogram as
the rise in arterial flow divided by the decrease in portal
flow as a percent (i.e. the bUffering capacity). The response
to adenosine infusion is expressed as the percent rise in
vascular conductance. The low dose of 8-PT decreased the
HABR, the response to adenosine and also reduced hepatic
arterial autoregulation (the curve becomes more linear). The
higher blocking dose of 8-PT produced further depression of
all three responses. The dose-related blockade of the HABR
and response to exogenous adenosine is in support of the
previously presented data of the quantitation and mechanism of
HABR series (Where MIX was used) and is also seen for
autoregulation.
Figure 17 shows pooled results (1 control and 1 blocked
response per cat) from the raised pressure group using
blockade by 8-PT (n=3) and 8-SPT (n=3). All responses were
antagonized. Note, however, that pooling the pressure-flow
curves tends to conceal the sigmoid shape of each individual
curve and presents a mean curve that implies an extremely weak
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Fig. 17 Pooled relationShip (n=6) of hepatic arterial
pressure (HAP) to hepatic arterial flow (HAF) presented as
percent of control flow, before and after bolus administration
of adenosine blocker (8-PT, n=3; 8-SPT, n=3). Effect of
adenosine blockers on hepatic arterial buffer response (HABR)
and adenosine response is represented by histograms. HABRis
expressed as rise in HAF divided by fall in portal flow (x
100%) elicited by complete occlusion of portal flow.
Adenosine response .is expressed as percent rise in vascular
conductance. Blood pressure was raised by aortic occlusion.
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autoregulation ~hat is difficult to quantitate for statistical
comparison with the curve obtained in the blocked state.
Assessment of linearity of the curve is one index·of the
presence of autoregulation. We used a new index, the
autoregulatory slope index, as a means of assessing linearity
of ttle curve. This index is based on the observation that
over the autoregulatory range the slope of the curve is less
than that seen below the autoregulatory range. The point at
which the. slopes deviate is the pressure at the low end of the
autoregulatory range and is referred to as the "shoulder ll •
Figure 18 shows these points on a hypothetical pressure-flow
curve" As the slope index (slope over autoregulatory range
divided by slope below autoregulatory range expressed as
percent) approaches 100%, autoregulation becomes blocked.
Table 2 shows significant blockade of autoregulation according
to this index.
The autoregulatory index (AR!) proposed by Semple and
DeWardener (1959) uses an approach that can avoid use of
mUltiple points on a curve. Pressures and flows are compared
in the basal state at some standardized pressure (lOOmmHg'in
our unraised pressure group; 120mmHg in the raised pressure
group) and at a lower pressure representing the point of the
shoulder on the pressure-flow curve (this point corresponded
to the pressure where resistance was the lowest on the
pressure-resistance curve). This index is a measure of the
proportional change in flow divided by the corresponding
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Fig. 18 Hypothetical pressure-flow curve showing
autoregulation. Shoulder corresponds to point of minimal
resistance on a pressure-resistance curve. Calculation of
slope index as an index of linearity of the curve above
(autoregulatory range) and below the shoulder is shown. Slope
below the shoulder is taken over the linear portion above the
tail near the critical closing pressure. Regression analysis
over these ranges can compensate for slight non-linearity.
Slope index of 100% indicates no differential change in
resistance along the curve and no autoregulation. This index
does not depend on calculation of vascular resistance with its
inherent limitations.
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prbportional.ch~nge.in pressure. The autoregulatory index was
significantly altered by the adenosine antagonists in both
groups (Table 2). The mean control ARI (raised pressure
group) using uncorrected pressure gradient was 0.882 + 0.048,
0.823 + 0.045 when portal pressure was subtracted and 0.782 ±
0.046 when eriticalclosing pressure was subtracted from HAP.
All ARlwere significantly raised by adenosine antagonists.
Autoregulation implies that arterial resistance changes
in response to altered perfusion. Mean resistance decreased
progressively as pressure dropped to 70 + 6mmHg (range 50-
90mmHg) (the shoulder of Figure 18) while at lower pressure
the resistance rose. To assess the existence of statistically
significant hepatic arterial autoregulation, the difference
between control hepatic arterial resistance (HAR) (at HAP of
120mmHg in the raised-pressure series) and HAR at the shoulder
was tested. The change in HARwas significant whether portal
venous pressure (P<O.05) or critical closing pressure (P<O.01)
was used to correct for the pressure gradient. However, the
change was not significant when uncorrected pressure gradient
was used. There was no .statistically significant differ·ence
between portal venous pressure and critical closing pressure
values. Figure 19 shows mean data from the raised pressure
group, standardized from basal resistance at arterial pressure
of 120mmHgandexpressed as a percent of basal resistance at
10mmHg pressure decrements over the autoregulatory range from
individual curves. These data show the clearest graphic
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Fig. 19 Relationship of percent change in hepatic arterial
resistance (%!J. HAR) to hepatic arterial perfusion pressure
(HAP) over the autoregulatory range, before and after
adenosine blocker bolus administration (n=6). Same group of
animals as reported in Table 1 and 2, and Figure 17.
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demonstration of autoregulation and blockade by adenosine
receptor blockers. Table 2 shows the calculated percent
change in. resistance for both groups and clearly indicates
that change in hepatic arterial resistance is prevented by the
adenosine antagonists.
3.2.3 Effect of Norepinephrine and Isoprote:r;enol
Infusion on Hepatic Arterial Pressure-Flow Curve
Norepinephrine, when infused intraportally (O.lug.Kg-l.
· -1),m~n. , significantly decreased hepatic arterial basal
conductance (n=5) from 0.156 ± 0.020 to 0.102 ± 0.015 ml.min-l
.Kg-l.mmHg-l (P<O.Ol). Norepinephrine infusion significantly
increased the hepatic arterial critical closing pressure from
17.8 + 1.38 nunHg to 23.4 + 1.87 nunHg (P<O.Ol) as well.
Norepinephrine infusion induced no statistically significant
changes on the autoregulatory indices. However, there was a
trend to decrease the autoregulatory property of the hepatic
artery, since there was a small increase in slope index and
ARI values and decrease in percent change in HAR value.
(Appendix A)
Isoproterenol infusion (n=4) , ( -1' -1o•2ug •Kg •m~n intra-
portally) significantly dilated the hepatic artery and
increased hepatic arterial basal conductance from 0.189 ±
0.019 to 0.247 ± 0.025 ml.min-l.Kg-l.nunHg-l (P<0.05).
Isoproterenol decreased the hepatic arterial critical closing
pressure, however, the decrease was not statistically
significant. The isopro- terenol-induced dilation eliminated
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the autoregula~ory capacity of the hepatic artery. The
percent change in BAR was significantly changed from (-16.3 ±
6.3) to (10.1 + 8.9) (P<0.05); ARI increased from 1.07 ± 0.08
to 1.30 + 0.07; slope index increased from 50.1 ± 9.3 to 80.5
+ 19.2. (Appendix A)
3.3 VALIDATION OF THE SURGICAL PREPARATION
The microsphere study indicated clearly that splanchnic
organs still receive some arterial flow after SMA occlusion,
i.e. there was still some residual portal flow. This
indicates the presence of anastomotic connections between the
SMA and other arteries. The data indicated that the non-SMA
portal contribution was mainly at the site of the upper third
and the cardia of the stomach, and at the lower third of the
rectum. In other words, the non-SMA arterial connection sites
were mainly at the beginning and the end of the
gastrointestinal tract. Complete occlusion of the superior
mesenteric artery reduced portal flow to 8.49 + 1.36% of its
control value (portal flow was reduced from 75.28 ± 23.13 to
6.00 ± 1.51 ml.min-1 ; n=5) (Appendix C). However, correlation
between portal blood flow (calCUlated from microsphere
radioactivity) and SMA flow (correspondingly measured by the
flow probe) was extremely poor (r=O.64). When portal flow was
corrected for by subtracting the residual portal flow (after
SMA occlusion), the correlation with SMA flow was highly
significant (P<O.0001). The correlation coefficient (r) was
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0.998. It was ,concluded, therefore, that changes in SMA flow
measured by the use of a flowprobe were representative of
changes in portal flow in our preparation. The same
microsphere study indicated that the contribution of the
hepatic arterial flow to total liver blood flow was 39.63 ±
2.40% (n=5) , a value insignificantly different from that
presented in Table 1 calculated from flow·probe measurements.
The microsphere study indicated also that SMA occlusion
,insignificantly changed cardiac output·· from 136.62 +·28.50 to
128.23 ± 25.03 ml.min-1 .Kg-1 and blood pressure from 111.4 ±
9. 7 to 110.6 + 12.0 mmHg. SMA occlusion reduced the pUlse
from 226 ± 9 to 218 ± 8 beat/min. This reduction was found to
be significant statistically (P<0.05) (Appendix C). Since the
cardiac output and blood pressure did not change in our
preparation during SMA occlusion,the percent of the non-SMA
contribution to the portal flow is believed to be the same
during the control state.
In an incomplete study, I tried to study HABR in
conscious cats using the microsphere technique. Although HABR
results were inconclusive (Appendix D), some control data were
useful. The spleen contributed 21.79 + 1.76% (n=6) to total
portal blood flow in conscious cats. Clearly removal of the
spleen, as with our preparation, would deprive portal flow
from a significant contribution of its inflow. The few
numbers of animals tested so far would not allow for valid
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unpaired statistical comparison between portal (and hepatic
arterial) flow during anesthetized and conscious state.
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4. DISCUSSION
4.1 GiNEEAL CO~SIDiRATIONS
Despite the early observation of.the HABR by Burton-Opitz
(1911), many sUbsequent researchers failed to detect such a
response. Studies that support the existence of the buffer
response were mainly derived from preparations in which the
hepatic artery was not long-circuited, whereas, preparations
with long-circuited or artificially perfused hepatic arteries
showed no or weak HABR (Greenway and stark, 1971). Therefore,
it was essential to have a whole animal preparation with an
intact hepatic artery to study the hepatic arterial buffer
response and autoregulation. Nevertheless, it· should be
pointed out that many of our whole animal preparations failed
to exhibit the bUffer response after the end. of the surgical
preparation and the stabilization period (30 minutes) that
follows. The reason is unclear to us. Postmortem examination
of the animals revealed heavy round and/or tape worm
infestation in some cases, in others no clear pathological
reason could be detected. Regardless of the reasons behind
the unsuccessful preparations, we observed that any
preparation that failed to show HABR failed to dilate . in
response to the externally infused adenosine and vice versa.
The hepatic artery in such an adenosine non-responding
preparation is reactive to other. vasoactive compounds such as
norepinephrine. On two occasions I infuse·d a low dose of
norepinephrine into the hepatic artery, to induce partial
constriction, and tested for the recurrence of the adenosine
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and the buffe.r ~esponse. Neither one recurred. Around 60% of
cats prepared forthequantitation series failed. toshowHABR
and adenosine response. The majority were infested with worms
or given antihelmenthic medications recently. Around 50% of
cats prepared for the autoregulation series were excluded f·or
the same reason. It seems that the mechanism of the HABR is a
sensitive one since re-entry into the abdominal cavity and
manipUlation of the intestine weakened the bUffering capacity
in.some preparations. Therefore, care should betaken during
the surgical preparation to induce as little surgical trauma
as possible.
4.2 METHODOLOGY
The use of a whole animal preparation with intact hepatic
arterial and superior·mesenteric arterial circulation has many
advantages and disadvantages. The advantage is. to improve the
chance of detection of the hepatic arterial buffer response
and hepatic arterial autoregulation, and to simulate, as much
as possible, the normal physiological situation. However, the
preparation we used has many limitations. The inability· to
raise the superior mesenteric flow (i. e. portal flow) to
levels higher than control limits us to testing the hepatic
arterial buffer response in one direction, i.e. to decrease
portal flow and. measure the rise in hepatic arterial flow,
whereas, in normal physiological situations portal flow
fluctuates above and below control. The dilation of the
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superior mesenteric artery by the use of locally infused
dilators was not a practical solution to this obstacle since
the dilator can reach the liver through portal flow and affect
the hepatic artery.
The preparation limited us to test autoregulation within
a small range (from control HAP to shoulder). Studies testing
autoregulation over a wider range used either the hepatic
arterial long-circuit, to be able to increase the perfusion
pressure,. or used the isolated perfused liver preparation
(Greenway and Stark, 1971). The use of the arterial long-
circuit can render the hepatic artery less reactive (Greenway
et al., 1967). To raise hepatic arterial pressure head
without the use of a hepatic arterial long-circuit, occlusion
of the aorta below the kidneys was applied. This procedure
was tried before by Stokland et al., (1981) and was shown to
produce elevation in arterial pressure with no effect on
cardiac output, stroke volume or myocardial shortening.
However, Stokland' s group made the occlusion of the aorta
above the kidneys. We occluded the aorta below the kidneys to
avoid the possibility of the stimulation of the renin-
angiotensin system that might affect the validity of our
results. The rise in pressure in this situation is due to the
increase in peripheral resistance, a situation similar to some
physiological hypertensive states. Our data showed that
aortic occlusion did not affect the basal parameters of the
hepatic artery and did not affect the shape of the pressure-
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flow curve. However, the aortic occlusion showed a trend to
shift the curve up and to the left slightly. This observation
is similar to that made by Torrance (1961) with
pharmacological denervation of the liver. Nevertheless, the
mean rise in systemic blood pressure was 13-14mmHg, a finding
similar to that observed with occlusion of the aorta above the
kidneys (Stokland et al., 1981).
For the superior mesenteric flow to be synonymous with
portal flow, splenectomy was a· prerequisite. The splenic
artery is a branch of the celiac artery (Figure 6) and there
is no anastomotic connections between the splenic circulation
and the superior mesenteric artery such as the case with the
superior and inferior mesenteric artery. Therefore, ligation
of the splenic artery alone would end with ischemia of the
whole spleen. Moreover, it is difficult to approach the area
of the celiac artery, the superior mesenteric artery and the
splenic veins to apply flow probes and vascular occluders, and
to cannulate some splenic veins, While the spleen is still in
place. The .disadvantage of splenectomy, on the other hand, is
that it deprives portal flow from a significant amount .of
portal input. Our data indicated that the spleen contributes
22% to total portal blood flow in conscious cats (Appendix D).
Clearly this partial reduction in portal blood flow might
stimulate some increase in hepatic arterial flow (HABR). This
is evident from control data presented in Table 1. The
hepatic arterial contribution to total liver blood flow was
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around 40% in our preparation compared to 25% in others
(Greenway and Stark, 1971; Mathie and Blumgart, 1983).
Therefore, data obtained from such a preparation may
underestimate the control "Value of the HABR.
Measurement of portal blood flow by direct application of
a flow probe on the portal vein has been applied by many
research workers in diffe~ent kinds of animal species.
However, the attempt to try such a procedure in our laboratory
on cats failed· to give consistently reliable measurements.
Application of the flow probe on an artery gives much more
stable and reliable measurements compared to that of a vein.
It seems that the collapsible nature of the veins does not·
allow proper intimate contact between the portal vein wall and
electrodes of the flow probe. Such intimate contact is
essential for the conduction of the electromagnetic signal
from the flow probe to the flowmeter. In addition, portal
venous flow is difficult to accurately calibrate. To avoid
this obstaple, we applied the flow probe on the superior
mesenteric artery with the inferior mesenteric artery,
gastroduodenal artery and gastric artery being ligated.
Therefore, portal flow in our preparation is derived almost
entirely from the superior mesenteric artery. Nevertheless,
this methodology should be validated to prove that arterial
flows, other than that from the superior mesenteric artery,
have no significant contribution to portal blood flow. To do
so, in a pilot stUdy, two radioactively labelled (57Co and
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113Sn ) microspheres (16U in diamter) were injected.> at the
ascending arch of the aorta. One batch was administered
before the SMA occlusion to serve asa control, the second was
administered after the occlusion. Our data indicated clearly
that occlusion of the SMA in our preparation did not
completely eliminate the portal flow (Appendix C).
Nevertheless, the non-SMA contribution to portal flow did not
cause any significant error in calculating SMA flow changes.
The lack of existence of any ischemic regions in the
splanchnic organs, in our preparation, suggests strongly that
the anastomotic connections between the SMA and other
splanchnic arterial beds were efficient. Ligation of the
inferior mesenter.ic, gastric and gastroduodenal arteries were
fUlly compensated for through the anastomotic connections with
the SMA. However, some non-SMA flow was still reaching the
gastrointestinal tract mainly at its two ends. It seems that
some fine arteries, directly originated from the abdominal
aorta, are responsible for this non-SMA contribution. It is
interesting to note that these very sites are the sites of
anastomosis between portal vein and systemic venous
circulation. These anastomosis are known to shunt portal
blood to the systemic venous circulation during some portal
hypertension cases.
The microsphere study indicated as well that occlusion of
the SMA has no significant effect on hemodynamics. Cardiac
output and systemic blood pressure showed insignificant
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changes. ·in resP9nse to the .SMA· occlusion. The study support~d
the observation that the proportion of hepatic arterial flow
to total liver blood flow is higher in our preparation (40%)
compared to the 25% proportion obtained from non-
splenectomized preparations (Mathie and Blumgart, 1983).
Despite some limitations, our data and the discussion
presented above support the conclusion that the preparation
and methodology used in this research work were valId and
capable of· testing the· HABR and pressure-flow autoregulation
in the hepatic artery, as well as their mechanism of action.
4.3 THE QUANTITATION OF THE HEPATIC ARTERIAL BUFFER RESPONSE
Despite the frequent demonstration of the HABR by many
investigators, no real attempts have been made to quantitate
the bUffering efficiency of the hepatic artery in a systematic
way. This lack of information might be attributed to the
difficulty in correlating between the hepatic arterial flow
and portal venous flow in the presence of many variables.
Within the same experimental procedure, the control hepatic
arterial flow and conductance can change in response to
alterations in cardiac output, systemic blood pressure,
circulating blood volume or portal flow. Therefore,
quantitation of the HABR should be conducted in a model that
can maintain these parameters as steady and stable as
possible. It is evident from our data that the hepatic
arterial bUffering efficiency, in response to wide range
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changes in port~l flow, was not constant even when the hepatic
arterial perfusion pressure was held steady. The highest
bUffering efficiency of 24.24% was reached at 60t decrease in
portal flow, i. e. 24% of the reduction in portal flow was
compensated for by the increase in hepatic arterial flow
(Figure 9). Further reductions in portal flow were less
compensated for by the hepatic artery. However, when the
hepatic arterial perfusion pressure was allowed to rise during
the induction of. the HABR (i.e. uncontrolled HAP), the
bUffering efficiency of the HA was constant with an average
compensatory capacity of 30.30% (Figure 11). Some previously
available information had indicated, without quantitation, a
non-linear relationship between changes in hepatic arterial
flow and portal flow. Hanson and Johnson (1966) found that
hepatic arterial flow tended to reach a plateau value at very
low portal venous flows. Recalculating their mean data showed
that a peak HABR of 8% was reached at 66% decrease in portal
flow, when portal blood flow was further decreased the
bUffering efficiency decreased as well. Considering that HAP
decreased during their procedure and the HA and portal vein
were long-circuited, the authors data were surprisingly in
close agreement with our findings. In contrast with Hanson
and Johnson's (1966) findings, Gelman and Ernst (1977)
observed that the increase in hepatic arterial flow became
more and more pronounced as portal venous flow was reduced,
i.e. the more the reduction in portal flow the more efficient
105
the HA became to buffer portal flow changes. However,the
hepatic hemodynamic changes recorded from this study were
induced by the direct infusion of acids and sodium bicarbonate
into the portal vein. This infusion altered significantly the
composition of portal blood and affected the systemic arterial
and venous blood pH. The same study showed that a decrease in
portal blood pH led to an increase in hepatic arterial flow
when portal flow was held steady, whereas lowering of arterial
blood pH due to theintraportal infusion of hydrochloric or
lactic acid caused significant reduction in portal blood flow
and an increase in hepatic arterial flow. An induced increase
in portal blood pH led to an opposite but weaker change in
hepatic arterial flow. Although the reason behind the pH
induced reduction in portal blood flow was unclear,
nevertheless, it seems possible to conclude that the increase
in the bUffering efficiency at lower portal flows might be
attributed to the additional dilation of the hepatic artery in
response to the H+ ion delivery through portal blood. Despite
the employment of an in vivo artificial perfusion of the liver
by the above two groups of authors, it is likely that the more
physiological preparation of Hanson and Johnson may have
yielded a more representative set of results.
The best attempt to quantitate the HABR, so far, was the
study of Mathie and Blumgart (1983). This group of authors
evaluated the bUffering capacity of the hepatic artery in dogs
that were anesthetized and had undergone the acute stress of
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establishment of a side-to-side mesocaval anastamosis. This
preparation allowed the controlled reduction of portal flow
without inducing any reduction in venous return, hence,
systemic blood pressure was held steady. Although the hepatic
arterial response to portal flow changes was tested over a
wide range of acute altered portal venous flow, theHABR was
not related to gradual or stepwise reductions in portal blood
flow. Therefore, data points were scattered between the
minimum and maximum portal flow level reached. Data points'
were found to fit a linear relationship with a line of best
fit equation: Y ~ 0.24x - 0.32; where Y and x signify hepatic
arterial and portal flow changes respectively. Hence, the
pooled bUffering capacity was 24%. The authors recalculated
their data to quantitate the buffering efficiency from each
individual experiment. The mean bUffering efficiency value
calculated from their scattered HABR data was 22.7 + 2.0%, a
figure very close to 24.24% derived from our data at 60%
decrease in portal flow. However, the authors neither
indicated whether individual data points of bUffering
efficiency were statistically insignificantly different from
each other, nor revealed whether the linear relationship
between portal flow alterations and hepatic arterial flow
response was statistically significant. Nevertheless, the
results derived from the Mathie and Blumgart (1983)
preparation are in close agreement with our pressure-
uncontrolled HABR data where bUffering efficiency was found to
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be steady with a mean value of 30.30%, despite the difference
in species, preparations, and methods of induction of the
HABR.
In this study the buffer capacity of the hepatic artery
was quantitated in the form of absolute and percent change in
hepatic arterial conductance as _well. The hepatic arterial
conductance (HAC) reached a plateau value at 60% decrease in
SMAF (portal flow) (Figure 13), whereas the percent change in
HAC revealed a continuous increase in response ~o the
progressive decrease in portal blood flow (Figure 12), to
reach a peak value of 28. 68% at complete occlusion of the
superior mesenteric artery. Our finding is similar to that of
Hanson and Johnson (1966) , Who oDtained a curvilinear
relationship between portal flow and hepatic arterial
resistance, but different from that calculated by Richardson
and Withrington (1978) who observed a linear association
between portal venous pressure (and flow) and hepatic arterial
resistance. However, it should be pointed out that the latter
authors employed pump operated hepatic arterial and portal
venous long-circuits in their preparation. Recalculation' of
their mean data to compare them with ours revealed significant
differences. The basal hepatic arterial resistance was close
to 16 compared to 5 nunHg.ml-1 .min.Kg obtained from our data.
Their critical closing pressure was extremely high (40mmHq)
compared to ours and 100% occlusion of portal venous flow
caused about 15% increase in HAC and 11% HABR capacity, values
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close to hal~ of that obtained from our preparation,
indicating weak buffering efficiency. These findings are in
agreement with the observation made before (Greenway and
Stark, 1971) that long-circuited preparations demonstrate weak
or absent bUffering efficiency in the hepatic artery.
However, there would seem to be general -agreement that
increases in hepatic arterial conductance are intimately
related to the increases in hepatic arterial flow observed
when portal venous flow is reduced. The presence of some
degree of pressure-induced hepatic arterial autoregulation
during pressure-uncontrolled HABR may support the observation
of the mutual existence of hepatic arterial autoregulation and
HABR.
The hepatic buffering efficiency range of 24-30% obtained
from our research work does not differ from the average buffer
capacity of 25% seen in several series conducted in our
laboratory. A compensation for one-quarter of a reduction in
portal flow does not sound physiologically significant for
maintaining total liver blood flow rates. Such criticism is
quite valid, however, several facts suggest that the buffer
capacity of the hepatic artery is underestimated by the
methods used to study the response. The exposure of animals
to the anesthesia and the acute surgical stress result in
mesenteric vasoconstriction (McNeill and Pang, 1982), and
subsequently lower portal blood flow. Further reduction in
portal flow would be added due to splenectomy. Therefore,
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portal bloodf~ow.would be unusually low. This would partly
trigger the buffer response before we test for its presence.
It has been pointed out already that the contribution of the
hepatic" artery to total liver blood flow in our preparation
(40%) was higher than that (25%) obtained "from other studies.
This finding is in support with the existence of partially
stimulated HABRin our preparation. Thus, while the described
methods were suitable for producing" a reproducible response
for mechanistic studies, the quantitative value of the buffer
is not physiologically relevant.
The hepatic arterial buffer response can be observed and
quantitated in many studies, although the HABR was not being
studied per see The methods.used in these studies were widely
variable and ranged from anesthetized acute preparations to
conscious chronic ones. Hemodilutions (Lautt, 1977b) and
metabolic inhibitors and stimulators (Lautt, 1980) produced
alterations in portal flow, with the hepatic arterial flow
compensating to hold total blood flow steady. Hughes et ale
(1980) produced lactic acidosis in dogs and observed an
increase in portal" blood flow and a dramatic decrease "in
hepatic arterial flow, reSUlting in no change in total hepatic
blood flow, i.e. 100% HABR capacity. This complete
compensation of the hepatic artery took place despite the fact
that oxygen delivery to liver cells and hepatic venous oxygen
content declined. Lagerkranser et ale (1984) tested the
effectiveness of adenosine for inducing controlled
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hypotension. Despite the direct vasodilatory effect of
adenosine on the hepatic artery, intravenous or intra-arterial
infusion of adenosine caused 64% decrease in preportal
vascular resistance, while hepatic arterial resistance
increased by 49% (i.e. vasoconstriction); The increase in
portal blood flow was completely compensated for by the
decrease in hepatic arterial flow resulting in no chanqe in
total hepatic blood flow as well. similar conclusions can be
derived .from·· several conscious preparations. In two cirrhotic
rat models (Fernandez-Munoz et al., 1985; Lebrec and Blanchet,
1985), the hepatic arterial blood flow was altered to offset
chanqes in portal blood flow induced by the cirrhotic
processes. In one model (Fernandez-Munoz et al., 1985), which
exhibited no significant porta-caval shunts, portal blood flow
was significantly elevated and the hepatic arterial flow was
reduced sUfficiently to hold total hepatic blood flow at
similar levels in the control and cirrhotic animals. All
other arterial flow (muscle, testes, kidneys and splanchnic
organs) were elevated and conductances were increased. The
vasoconstriction of the hepatic artery was unique since all
other arteries showed vasodilation, implying that the buffer
overcame some general systemic dilator influence and yet
produced an impressive compensation. The other model (Lebrec
and Blanchet, 1985) produced biliary cirrhosis and portal
hypertension. portal flow was reduced, due to reduced
splanchnic blood flow, and the hepatic arterial flow was
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elevated. The increase in the hepatic arterial flow fully
compensated for the reduction in portal flow and held total
liver blood flow at a level similar to that of control, i.e.
it exhibited 100% buffer capacity. The majority of the data
presented above give the impression that the buffer capacity
may be considerably more effective in compensating for portal
flow elevations than for reductions in portal flow, and that
the buffer capacity may be higher in conscious preparations
than in ane.sthetized ones. Unfortunately, the lim!tations and
the design of our preparation did not allow us to test such a
speculation.
Data derived from several hemorrhagic studies suggest
strongly the presence of an effective HABR, however it is
diffiCUlt to quantitate the response. In most of these
studies the cardiac output decreased during hemorrhage and
total hepatic blood flow significantly decreased, despite the
evident dilation of the hepatic artery (Greenway and Stark,
1971). After hemorrhage, portal flow decreased due to
arteriolar vasoconstriction in the spleen and intestine,
however I total hepatic flow decreased approximately . in
proportion to the decrease in cardiac output. The decrease in
portal flow was proportionately greater than the decrease in
total hepatic blood flow (Greenway and Stark, 1971). The
hepatic arterial flow was either unchanged (Mundschau et al.,
1966) or increased (Slater etal., 1973) in spite of the fall
in arterial pressure head. Thus, after hemorrhage the hepatic
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arterial flow tormed a higher proportion of the total hepatic
flow. Replacement of the hepatic arterial and portal venous
flows by their corresponding percentage· of cardiac output
showed that during hemorrhage the decrease in portal flow
percentage of cardiac output was compensated for by the
increase in hepatic arterial pereentage of cardiac output.
Hence,during hemorrhage the hepatic artery holds the total
hepatic flow percentage of the cardiac output steady (Slater
et al., 1973; Kaihara et al., 1969). This peculiar role of
the hepatic artery during the reversible hemorrhagic shock
state raises the speculation that, when the buffer capacity
fails to maintain a stable total hepatic flow in the face of
reduced cardiac output and blood pressure, it maintains a
constant proportion of the cardiac output for the hepatic
vascular bed.
4.4 ADENOSINE AND ADENOSINE RECEPTOR BLOCKERS
4.4.1 Adenosine
Adenosine is one of the purine compounds whose profound
hypotensive, sedative, antispasmodic, and vasodilatory actions
were first recognized over five decades ago (Drury and Szent-
Gyorgi, 1929). Over the years the number of biological roles
suggested for adenosine and for precursor adenine nucleotides
have increased tremendously. Extracellular adenosine
receptors and adenine nucleotide receptors have been
identified (Bruns et al., 1980; Schrader et al., 1977). In
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many cells the adenosinerecE!ptors appear linked to adenylate
cyclase, while nucleotide receptors lsuchas ATl? receptors)
probably control ion fluxe.s (Fox and Kelley, 1978). Adenosine
may represent a generalrequlatory substance, since many. cell
types seem capable of synthesizing it." Unlike various
endocrine hormones, there is no evidence for storage and
release of adenosine from nerves or other cells. The presence
of purinergic nerves has been proposed in peripheral systems
(Burnstock, 1978)," butATPratherthan adenosine has been
considered the neurotransmitter in such nerves.
Adenosine has different physiological roles in different
organs. In the cardiovascular system, intravenous (or intra-
arterial) infusion of adenosine leads to arterial vasodilation
and hypotension (Lagerkranser et al., 1984),. and also leads to
cardiac depression (i.e. negative chronotropic and inotropic
effects) (Prasad et al., 1980). Unlike other vascular beds,
renal arterioles constrict in response to adenosine infusion
(Hedqvist et al., 1978). The antispasmodic and vasodilatory
actions appear linked to smooth muscle depressant effects of
adenosine. Such depressant effects are perhaps linked to
activation of muscle adenylate cyclase (McKenzie et al.,
1977). Adenosine has inhibitory effects on neurotransmission
and on spontaneous activity of central neurons. The
mechanisms are unknown but certainly involve calcium and may
involve presynaptic inhibition of adenylate cyclase (Hedqvist
et al., 1978; Philliset al., 1979; stone, 1981a). The
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reversal of the.inhibitory·effects of adenosine on.cholinergic
and noradrenergic transmitter release by calcium ions has· led
to adenosine and its analogues being referred to as calcium
antagonists (Silinsky, 1981; stone, 1981b). Less attention
has been given to the antilipolytic and antithrombotic action
of adenosine compared to the cardiovascular and neural
function effects of adenosine.
The inform.ation available on the physiological roles of
adenosine in the hepatic. circulation is scarce. Most of the
studies were directed to understand the roles of adenosine or
its analogues o~ hepatocyte biological processes. However, it
has been pointed out in the introduction that hepatic blood
flow is not linked to its metabolic processes, and that the
anatomical arrangment of the acinus does not allow any
biological end products released from the hepatocytes to get
access to resistance sites upstream. External1yadministered
adenosine causes vasodilation of the hepatic artery (Greenway
and stark, 1971). In contrast with the reduced oxygen uptake
by the myocardial and preportal tissues, the liver responded
to adenosine infusion by an increased oxygen uptake. In other
words, the increased hepatic oxygen uptake shows that the
liver responds in a different manner from· other tissues
exposed to exogenous adenosine (Lagerkranser et al., 1984).
This may be explained by an enhancement of the oxygen
consuming process in the hepatocytes, such as increased
gluconeogenesis (Haeckel, 1977) , stimulation of hepatic
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adenylate cyclase (Schutz et al., 1982) and incorporation of
adenosine and its metabolites into intracellular ATP.
The liver is a major supplier of adenosine to the
systemic circulation. Adenosine levels in hepatic venous
blood are tenfold portal and arterial levels (pritchard et
al., 1975). The liver effectively removes 80t of
hypoxanthine, xanthine and urate (i.e. oxypurines) in a single
passage of blood through the liver and converts them to
utilizable purine (adenosine) (pritchard et al., 1975). It is
believed that this exported adenine derivative is utilized by
cells and tissues (such as erythrocytes, leukocytes,
gastrointestinal mucosa and bone marrow) which are totally
incapable, or at least markedly defective, in de novo purine
synthesis despite having a high rate of purine turnover
(Pritchard et al., 1975). However, it is unclear yet which
cell type in the liver is responsible for the clearing of
hypoxanthine from afferent blood and the simultaneous addition
of adenosine to efferent blood. The hepatic arterial buffer
response cannot be explained according to this physiological
adenosine production from the liver. First, the adenosine
release is downstream, while the vascular resistance sites are
upstream. Second, the efficiency of hypoxanthine conversion
to adenosine was maintained in isolated perfused liver
preparation, a situation where the bUffering capacity is known
to be markedly attenuated.
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Two mechanisms to explain adenosine release from cells
have been proposed. One possible mechanism is that adenosine
is made at the surface of cells by 5 t -nucleotidase bound to
the plasma membrane (i.e. an ecto enzyme) (Frick and
Lowenstein, 1978; Berne, 1980). This enzyme is known to be
present in hepatocyte membrane (Drummond and Yamamoto, 1971).
The other possibility is that adenosine is made inside the
cell and leaves via passive and facilitated diffusion (Schutz
·et. al., 1981). The metabolic pathways involved in formation
and inactivation of adenosine are still poorly resolved
questions. Two metabolic pathways have been suggested (Figure
20) • Certainly, the most obvious pathway for formation of
adenosine involves ATP ~ ADP -. AMP as precursors and might
be called the "ATP Pathwaylt. Formation of adenosine via this
ATP pathway appears to increase considerably in cells under
conditions of high energy demands (i.e. there is energy
deficit) (Arch and Newsholme, 1978). Under such conditions,
5 ' -AMP levels increase intracellularly as levels of ATP
decrease due to excessive energy demands. Endo-5 1_
nucleotidase, thought to be freed from inhibition by ATP,
hydrolyzes 5 I -AMP to adenosine. Adenosine can then cross
biological membranes either actively or passively to reach
extracellular receptors. The ATP pathways can also occur
extracellularly , and this may, in some tissues, be a very
important route to adenosine. For example, ATP coreleased
with a neurotransmitter, such as norepinephrine or
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Fig. 20 Metabolism of adenosine. This diagram illustrates
the pathways by which adenosine is formed and degraded within
cells. Adenosine may also be transported into cells or
released from cells: 1, S-adenosylmethionine
methyltransferases; 2, S-adenosylhomocysteine hydrolase; 3,
adenosine deaminase; 4, purine nucleoside phosphorylase; 5 &
6, xanthine oxidase; 7, transport mechanisms; 8, adenosine
phosphorylase (not established); 9, adenosine kinase; 10, 5'-
nucleotidase and non-specific phosphatase; 11, adenylate
kinase; 12, nucleoside diphosphokinase; 13, adenylate cyclase
(Fox and Kelley, 1978).
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acetylcholine, can either act atATP. receptors or can be
hydrolyzed to adenosine by ecto-ATPasesand ecto-5 'nucleo-
tidase. Similarly, ATP might be released as a transmitter
itself to act on receptors then be hydrolyzed to adenosine.
Inhibition of the extracellular (membrane~bound)ATP pathway
can be achieved through the blockade of ecto-ATPases and ecto-
5 1 -nucleotidase, whereas attenuation of adenosine release from
the intracellular ATP pathway can be achieved by blocking the
adenosine transport system by dipyridamole and nitrobenzyl-
thioinosine (NBTI) (Belloni et al., 1985). Since dipyridamole
and NBTI inhibit adenosine uptake' (i.e. influx) as well,
therefore, they can be considered as bidirectional adenosine
transport blockers.
other than the physiological production of adenosine by
the liver, isolated hepatocytes release adenosine during
hypoxic conditions. This adenosine release from hypoxic
hepatocytes can be attenuated by inhibitors of facilitated
adenosine transport, but not by inhibition of ecto-5'-
nucleotidase (such as, , a-methylene adenosine diphosphate)
(Belloni et al., 1985). Therefore, the intracellular ATP
pathway is believed to be responsible for the hypoxic release
of adenosine by hepatocytes. These findings support the
speculation that hepatocytes produce and release (i.e. export)
adenosine all the time, and that adenosine release is enhanced
during periods of hypoxia. This export enhancement might be
important to the dependent peripheral tissue for the
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replenishment of their cellular mucleotide levels upon
regaining· a normoxic state. The adenosine hypoxic response
cannot explain the mechanism of the HABR,since the HABR is
not coupled to the oxygen demand of hepatocytes as discussed
earlier in the·introduction.
A second possible cellular pathway to adenosine formation
which does not involve ATP pathway (i.e. not coupled to oxygen
demand), was proposed, namely, the "methylation pathway".
Biological methylation·ihintact cells leads to the generation
of S-adenosylhomocysteine, which is converted by the enzyme S-
adenosylhomocysteinase to adenosine and homocysteine (Figure
20) • It should be noted that this reaction is readily
reversible. The methylation pathway, unlike the ATP pathway,
can serve not only to generate adenosine but can, in the
presence of homocysteine, serve to maintain very low levels of
the nucleoside within the cell. other enzymes whose function
may be to maintain low levels of intracellular adenosine are
adenosine deaminase (converts adenosine to inosine) and
adenosine kinase (converts adenosine to 5 1 -AMP).
Under normal conditions adenosine levels, both intra and
extracellularly, seem to be low. A variety of routes for
inactivation of adenosine are present in cells. These include
enzymes, such as adenosine deaminase, adenosine kinase, and s-
adenosylhomocysteinase, and uptake processes. These pathways
maintain low levels of endogenous adenosine (1-2mM or less
under most physiological conditions), extracellular adenosine
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levels probably also never rise under normal conditions above
l-2mM (Daly, 1982). Although cells produce adenosine to serve
certain regulatory roles, they inactivate adenosine quickly in
order to attenuate its cytotoxic property. It has been
suggested that irreversible interactions with s-
adenosyl~omocysteinemay represent the molecular loci for the
cytotoxicity of adenosine and adenosine analogues (Hershfield
and Kredich, 1978). Adenosine and adenosine analogues can
irreversibly inhibit the >enzyme S-adenosylhomocysteinase. as
well (Hershfield and Kredich, 1978) • The resultant
accumulation of analogues of S-adenosylhomocysteine causes an
inhibition of methylation pathways within the cells. The
relative importance of the catabolic and anabolic pathways for
adenosine in hepatic cells has not been well defined and
further investigation is undoubtedly required.
Adenosine deaminase converts adenosine to an inactive
metabolite, inosine. Inosine is further metabolized by
phosphorylases to hypoxanthine. Potent inhibitors for
adenosine deaminase are available, namely, deoxycoformycin
which is an irreversible inhibitor and erythro-9-(2-hydroxy-3-
nonyl)adenine (ERNA) which is a reversible inhibitor (Plunkett
et al., 1979; Skolnick et al., 1978). These deaminase
blockers are specific in their action and seem better than
adenosine uptake (or transport) inhibitors, such as
dipyridamole, in potentiating adenosine responses.
Combination of adenosine uptake and deaminase inhibitor causes
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an additive, and not mUltiplying, effect (Henderson et al.,
1977). It should be pointed out that many adenosine
analoques, such as 2-choloradenosine, are not substrates for
adenosine deaminase.
The other enzyme involved in the inactivation of
adenosine, namely, ~denosine kinase, converts adenosine to 5'-
AMP, which then enters into the metabolic pool of adenine
nucleotides. However, inhibitors of this enzyme have not been
widely used (Daly, 1982).
In addition to the enzymatic inactivation, adenosine is
sUbject to a high affinity uptake system which removes it from
the extraceullar compartment and, hence, from getting access
to extracellular adenosine receptors. Such an uptake system
may actually be tightly coupled to sites of extracellular
generation of adenosine and to the enzymes involved in
intracellular inactivation of adenosine. Inhibitors of the
adenosine-uptake system include dilazep, dipyridamole,
hexobendine and papaverine. Some ca++ channel blockers (such
as lidoflazine, flunarizine and nifidipine) are potent
adenosine transport inhibitors as well (Daly, 1982). Such
compounds potentiate adenosine responses, however, they should
be used cautiously, since most have other biological
activities, inclUding activity as phosphodiesterase inhibitors
(Fredholm, 1978).
Our data indicated clearly that the HABR and the hepatic
arterial autoregulation are adenosine mediated. The logical
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question at th~s stage is how to explain the washout theory
according to the discussion presented above regarding
adenosine physiology and mechanisms of formation. The
existence of two pathways to generate adenosine and the fact
that the HABR is not coupled to the oxygen demand or supply,
allows us to speculate that there are two independent pools
for adenosine release within the liver. One pool is at the
level of sinusoids where hepatocytes (and probably some other
cells such as Kupffer cells) clear afferent blood of
hypoxanthine, xanthine and urate (released from· other
peripheral tissue cells) and continuously release adenosine in
hepatic venous blood (efferent blood) and that this release of
adenosine increases in cases of hypoxia or energy deficit
where more adenine nucleotide derivatives are formed within
the cell. The mechanism of formation of this adenosine pool
might be through the ATP-pathway since it can be linked to
oxygen and energy demand. The other pool of adenosine is at
the space of Mall close to the hepatic arteriole resistance
sites. Adenosine is released continuously, and at a constant
rate regardless of the oxygen demand, in this pool from
specialized cells within the space of Mall. This locally
produced adenosine either gets access to act on adenosine
receptors on resistance sites of the hepatic arterioles, or is
washed away from the vicinity by the portal flow or hepatic
arterial flow (or even lymphatic flow) (Figure 5). Therefore,
the concentration of adenosine in this pool is regulated by
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hepatic blood flow rather than by oxygen demand. The
mechanism of generation of adenosine from these specialized
cells might be according to the methylation pathway. Clearly
much research remains to be done to determine the roles of
adenosine in hepatic hemodynamics. Very little is known about
the physiology of the space of Mall and its limiting plate.
The exploration of this area may be quite significant for the
proper understanding of blood flow regulation within hepatic
sinusoids.
4.4.2 Adenosine Receptors
The extracellular adenosine receptors are referred to in
some literature as P1 receptors to differentiate them from the
adenine nucleotide (P2 ) receptors ( i. e. ATP receptors). It
has now been recognized that there is not one but at least two
classes of adenosine receptors. One of these has a high
affinity for adenosine and, at least in some cells, couples to
adenylate cyclase in an inhibitory manner. These have been
termed the A1 receptors by Van Calker et al., (1979), and the
Ri receptors by Londos et al., (1980). The second class of
receptors has a lower affinity for adenosine and, in many cell
types, couples to adenylate cyclase in a stimulatory manner.
These have been termed the A2 receptors or Rs receptors. In
this thesis, the two classes of adenosine receptors are
referred to as Al and A2 receptors. Most, but perhaps not
all, adenosine receptors appear linked to adenylate cyclase.
At present very few actions of adenosine can be stated with
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assurance not ~o involve cyclic AMP system. One such action
is the stimulation of glucose oxidation in adipocytes by
adenosine and analogues (Souness and Chagoya de Sanchez,
1981) . This action does not appear to involve cyclic AMP
systems. The stimulatory A2 receptor is' more ubiquitous in
occurrence compared to the inhibitory A1 receptor (Bruns,
1980) . A1 receptor is present in adipocytes and heart and
brain cells (Daly, 1982). The adenosine receptors in the
liver seem to be of theA2class'(Londos et'al., 1980).
The best known antagonists (blockers) of adenosine
receptors are alkylxanthines, such as theophylline and
caffeine (Smellie, Davis etal., 1979). unfortunately, no
selective xanthine antagonists for either A1 or A2 adenosine
receptors have been developed yet. An 8-phenyl substituent to
theophylline confers very high affinity .at both A1 and A2
receptors. The following list is the rank order of potencies
of some xanthines versus both A1 and A2 adenosine receptor
mediated effects on adenylate cyclase. 8-Phenyltheophylline
(8-PT) > 1,3-dibutylxanthine > 3-isobutyl-1-methylxanthine
(MIX) > theophylline > caffeine > theobromine (Daly, 1982).
The adenosine receptor blocker 8-PT is twenty-fold more potent
than theophylline. The inhibition constant for 8-PT is about
0.2uM for both A1 and A2 receptor, whereas MIX inhibition
constant is about 2uM for A1receptor and SuM for A2 receptor
(DalY,1982). Therefore, S-PT is much more potent than MIX.
Many of thexanthines have other biological activities, in
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particular, inhibitory effect on phosphodiesterases (Smellie,
Davis etal., 1979) The inhibition of this enzyme prevents
intracellular degradation of cyclic AMP and results in an
increase in intracellular concentration of cyclic AMP. This
phosphodiesteras.e inhibition complicates the use of xanthines
as selective adenosine receptor blockers. Our data are in
agreement with the above information. 8-PT was a powerful
adenosine receptor blocker compared to MIX, it can be given in
bolus doses while MIX, administration requires its continuous
infusion. Theoretically an adenosine receptor blocker should
constrict the hepatic artery. S-PT led to some
vasoconstriction (Table 1; the unraised pressure series)"
whereas MIX administration led to significant dilation of the
hepatic artery, reduced the total peripheral resistance and
decreased the systemic blood pressure. This vasodilation of
the hepatic artery in response to MIX infusion, might be
explained according to its powerful phosphodiesterase
inhibiting property. The resultant accumulation of cyclic AMP
within the smooth muscle cells of the hepatic arterioles led
to a dilator effect that counters the expected constrictor
responses resulting from adenosine receptor blockade. Certain
xanthines, close in their chemical composition to MIX, such as
1-isoamyl-3-isobutylxanthine, are known to be much more potent
as phosphodiesterase inhibitors than as adenosine antagonists
(Smellie, Daly et al., 1979). Rec.ently, 8-(p-sulfophenyl)
theophylline (S-SPT) has been introduced as a.polar adenosine
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antagonist which should penetrate cells only to a limited
extent (Petrack et al., 1981). Unlike 8-PT, this polar
derivative is' not particularly potent, being comparable in
potency to theophylline itself (Daly, 1982). our data agree
with this finding. High dosage was required to reach the
blocking range. In some preparations the blocking range could
not be reached since we reached the saturation point of the 8-
SPT solution and higher concentrations could not be achieved
even with changing the pH. and temperature of the solution.
Therefore, 8-SPT was substituted with 8-PT in those
preparations. We do not recommend the use of S-SPT in whole
animal preparations basically for two reasons. First, it is
much less potent than 8-PT and second, it is quite expensive.
Continuous infusion of 8-SPT (similar to MIX) is uneconomical
and futile. Despite its adenosine receptor blocking property, .
S-SPT did not induce vasoconstriction in the hepatic artery
similar to 8-PT. However, our data cannot exclude the
presence of some inhibitory effects on phosphodiesterases or
any other biological activites. So far S-PT seems to be the
best xanthine antagonist available to stUdy adenosine receptor
blockade. It should be pointed out that S-PT is competitive
and specific in its action on adenosine receptors. It does
not alter responses to othervasoactive substances such as
norepinephrine and isoproterenol (Lautt and Legare, 1985).
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4.5 THE MECHANISM· OF .HABR AND AUTOREGULATION
The unified. hypothesis tested· is that the reduction in
hepatic arterial resistance that occurs in response to reduced
portal venous or hepatic arterial flow is dependent upon the
reduced portal or arterial flow washing away less adenosine;
the adenosine accumulation leads to vasodilation. Figure 5
explains the putative mechanism of the HABR and
autoregulation. Our results indicated clearly that HABR and
autoregulation were. adenosine mediated .: Adenosine receptor
blockers (MIX, 8-PT and 8-SPT) inhibited both the dilatory
response to the externally administered adenosine and the
bUffering capacity (Figures 14,15,17). Restoration of the
dilator response to infused adenosine was accompanied always
by restoration of the buffer response. The inhibition of the
HABR was evident regardless of the criterion of quantitation.
Figure 14 expresses the .inhibition of the HABR as a decrease
in percent change in HAC, whereas Figures 15 and 17 express
the inhibition as a reduction in the bUffering efficiency. It
can be argued, however, that MIX inhibition of the buffer
capacity can be attributed to the MIX-induced maximal dilation
of the hepatic artery. No adenosine dose-response plots have
been conducted in this study to show the maximal dilation of
the hepatic artery, and thereafter to conclude whether the
hepatic artery was maximally dilated during MIX infusion or
not. Nevertheless, such a test has been conducted elsewhere
(Lautt et al., 1985). MIX did not produce a maximally dilated
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hepatic artery ~uring its infusion in that study. Despite the
above mentioned side effects of MIX, the similarity between
its inhibitory effects on adenosine infusion andHABR, and
other adenosine receptor inhibitors (S-PT and 8-SPT), suggests
that the MIX inhibition was related to its adenosine receptor
blockade property per see
Since the quantitation and HABR mechanism series have
shown that adenosine mediated the HABR,and to test whether
:the dilator washout theory can explain autoregulation of the
hepatic artery as well, the autoregulation series was
designed. Our basic protocol was to obtain arterial
vasodilation to intraportal infusion of a test dose of
adenosine (0.4 mg/Kg per min), then to obtain and quantitate a
pressure-flow curve and a HABR and then to determine the
effect of selective, competitive adenosine antagonists on
these responses. Figure 15 shows a dose-related effect of two
bolus doses of 8-PT on the pressure-flow curve and on the two
indices of adenosine receptor blockade. The HABR and response
to infused adenosine show dose-related. antagonism consistent
with previous results (Lautt and Legare, 1985) and the
autoregulatory curves show graded blockade with the high dose
of 8-PT producing a nearly linear curve indicative of lack of
autoregulation. A similar effect on autoregulation, the HABR
and the response to adenosine infusion are seen in pooled
results from six cats in which blocking agents had inhibited
the response to infused adenosine and the HABR. It is clear
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from Figures IS, 17 ,and 19 and Table 2. that, regardless of
the means of data expression, autoregulation was . blocked by
thesemethylxanthenes. The response of the hepatic artery to
isoproterenol and norepinephrine·arenot antagonized by B-PT,
Elhowing the selective nature of the antagonism and indicating
that the artery can still dilate to othe:r stimuli (Lautt and
Legare, 19B5).
For adenosine to·. serve as the intrinsic dilator of the
washout hypothesis, four criteria should be met. First, it
should be a powerful dilator of the hepatic artery. Second,
portal blood must have access to the hepatic arterial
resistance vessels, i.e. intraportal infusion of adenosine
should dilate the hepatic artery. Third and fourth,
inhibition and potentiation of exogenous adenosine responses
should also inhibit and potentiate the buffer response and
autoregulation respectively. Our results sho\tied clearly that
the first three criteria have been met (Figures 14,15,17;
Table 2). In a previous stUdy (Lautt et al., 1985),
dipyridamole (adenosine transport inhibitor) increased the
bUffering efficiency from a control value of 23% to 34.2%. ·In
an unsuccessful series, I administered dipyridamole intra-
arterially (the hepatic artery) to test for autoregulation.
Instead of potentiating the HABR and autoregulation,
dipyridamole actually inhibited both respon.ses as well as the
response to infused adenosine. Reduction of the administered
dose could not solve the problem. It was concluded that
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dipyridamole is a very dose-sensitive compound to work· with.
The potentiation of the HABR and the response to infused
adenosine reported before (Lauttet al., 1985) was obtained
when the drug was administered intravenously. This suggests
that dipyridamole can have effects other than blockade of
adenosine uptake. It is noteworthy at this stage that
responses to infused adenosine, the buffer capacity and
autoregulation showed clear potentiation in all 8-PT studies,
during the wearing off o.f the blocking property as well as
.after very low dose administration of the blocker (0.1 mg/Kg).
It was difficult to maintain this potenti~tion response for
long intervals. The only explanation I can suggest to explain
this phenomenon is that S-PT at low dose may have more potent
affinity to block the adenosine uptake system than its
affinity to the adenosine receptors. The suggested alternate
methodology to study the potentiation of HABR and
autoregulation is to replace dipyridamole by adenosine
deaminase inhibitors . Despite the outcome of such a study,
the available information supports strongly the washout
hypothesis and that adenosine is the intrinsic dilator that
controls the buffer response and autoregulation of the hepatic
artery.
It has previously been concluded that the mechanism of
the HABR and autoregulation is myogenic (Greenway and Stark,
1971; Hanson and Johnson, 1966; Hanson, 1973). The ability of
papaverine, a potent direct smooth muscle relaxant, to abolish
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both the hepatic arterial buffer capacity and the hepatic
arterial autoregulation was considered as support for the
myogenic hypothesis (Hanson, 1973). However, a potent
vascular dilator like papaverine can mask the effect of
locally produced vasodilators as well. Therefore, papaverine-
induced inhibition of the buffer capacity and autoregulation
cannot differentiate mechanisms. To confirm this
interpretation we tested for autoregulation before and during
~nfusion .of isoproterenol (0. 2 ug/Kg· per min, intraportal).
The isoproterenol resulted in dilation of the hepatic artery
and eliminated the autoregulatory ability of the artery. As
stated before, it is unclear in our study and in studies
reported in the literature, why many animals do not show HABR
or autoregulation, but a low basal vascular tone can cert.ainly
prevent the response and may account for some of these
failures.
Administration of 8-PT or 8-SPT in blocking doses did not
cause significant alteration of basal hepatic vascular
parameters (Table 1) confirming previous results (Lautt and
Legare, 1985). Dose-related vasoconstriction is induced by·8-
PT but only after evidence of complete blockade of adenosine
has occurred. If adenosine is crucially linked to regulation
of the vascular tone in the hepatic artery, as we suggest, it
is unclear how vascular tone· can· remain unaltered (despite
some mild vasoconstriction) by low doses of 8-PT. However,
most compounds of the xanthine family possess some degree of
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anti-phosphodie~terase activity (Smellie, Davis et al., 1979).
The inhibition of this enzyme prevents intracellular
degradation of cyclic AMP and the resultant accumulation might
lead to a dilator effect that counters the expected
constrictor responses resulting from adenosine receptor
blockade. Regardless of the explanation for the lack of
effect of 8-PT on basal resistance, it is fortuitous since
these and related vascular studies would be difficu1t or
impossible to, perform under a state of massive
vasoconstriction or dilation. Since 8-PT caused mild
constriction (no mean change) in some cats we felt it was
important to determine if small amounts of vasoconstriction
would significantly effect autoregulation. Norepinephrine
infusion into the portal vein caused significant
vasoconstriction but did not significantly alter
autoregulation jUdged by several indices. This would suggest
that altered basal hepatic nerve activity would also leave
autoregulation unaltered. Torrance (1961) found that ganglion
blockade by hexamethonium did not alter the shape of the
pressure-flow curve but it did shift it somewhat up and to the
left. Atropine did not alter the shape or position of the
curve in his study. Most previous studies were reported in
denervated livers but we specifically left the hepatic nerves
intact.
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4.6 METHODS OF. QUANTITATING AUTOREGULATION
All methods of qtlantitation of autoregulation involve
manipulation of data derived from a pressure-flow curve.
Figure 18 shows a hypothetical curve similar to the curves
obtained from individual or pooled experim$nts (Figures 15 and
17). The classical shape of a pressure-flow curve is sigmoid
and concave to the pressure axis. At zero flow the curve
intersects the pressure axis at the critical closing pressure
(Ccp) , a pooled value averaging 11.5. ± 1.4 mmHg, which· is
slightly but significantly (P<O. 02) higher than the portal
venous pressure (8.5 ± 0.6 mmHg). A pressure-flow curve is
not a form of data presentation that allows qtlantitation of
autoregUlation without further data manipUlation.
Quantitation of autoregulation can be done in several ways
and, for demonstration of blockade of autoregulation, the
index used must be carefully evaluated. The need to
standardize the pressure ranges tested in the control and
blocked state is the most obvious of the requirements. In
addition, the autoregUlatory index used must give a
quantitative value that can be statistically compared ·in
various states. While the change in the shape of the
pressure-flow curve, as seen in Figures 15 and 17, is
qualitatively convincing of reduced autoregulation, further
data manipUlation is required to allow useful statistical
comparisons. The earliest studies used changes in calculated·
vascular resistance as a means of quantitation.
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Parenthetie.ally, we advocate the use of conductance (the
inverse of resist.ance) as an index of arterial t.one, as
suggested by Stark (1968). An example of the distort.ionthat
resistance calculation imposes on data is seen where
resistance is calculated to rise to infinity at low pressures.
Conductance, on the other hand, decreases to zero, a value
that can be mathematically used and that intuitively is lUore
appealing. Nevertheless, the literature on autoregulation has
exclusively used resistance calculations ,and we have conformed
to that method for ease of comparison.
Calculation of resistance or conductance is problematic
because it requires that assumptions be made about the
appropriate pressure gradient across the resistance vessels.
Virtually all of the early studies used arterial minus venous
pressure and were required to report data for total vascular
resistance. Ideally, the pressure gradient across the
arterial resistance vessels should be used if the data are to
reflect events at the arterial resistance site. The practical
problem, .however, is severe and depends on the fact that one
cannot accurately and continuously measure capillary blood
pressure. The use of critical closing pressure in some later
reports and the introduction of the autoregulatory index and
its common usage indicates some of the attempts to more
realistically reflect events at the arterial resistance site.
It is noteworthy that calculation of resistance using zero
venous pressure was the only means that did not show clear
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autoregulation. in the control state. The use of either ccp to
calculate· the pressure gradient, for resistance changes or for
the autoregulating index, showed the presence of
autoregulation in the control state and its reduction after
adenosine blockade.
The theoretical advantages and disadvantages of critical
closing pressure use are of significance for most tissues and
the logic for its use lies in the assumption that, if flow
stops at a given arterial pressure then that arterial pressure
is not contributing to a functional pressure gradient at any
flow. However, the obvious obj ection is that the physical
conditions that lead to complete collapse of the blood vessels
at zero flow may have absolutely no relevance to vascular
status during flow state. Fortunately, this problem is
resolved in the liver because one can accurately and
continuously measure sinusoidal pressure and can therefore
accurately calculate the arterial pressure gradient. Recent
reports (Lautt, Greenway et al., 1986; Greenway et al., 1985;
Lautt et ale , (in press) ) indicate that, under basal
conditions, inclUding during complete occlusion of the hepatic
artery, virtually all of the pressure drop from the portal
vein to the inferior vena cava occurs across hepatic veins,
that is, the sinusoidal pressure is insignificantly (0.2 - 0.6
mmHg) lower than portal venous pressure. All calculations of
autoregulation have also been done using PVP as a correcting
factor to calculate pressure gradient across the hepatic
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arterial resi~ta.nce site before the blood enters the
sinusoids. It is interesting that the close correspondence of
the ccpand PVP resulted in no significant differences in
calculated resistance or cha.nges in resistance regardless of
which pressure was used. Clearly, however, the ideal
situation of accurate estimation of arterial pressure gradient
across the resistance site of the artery can be made and
should, therefore, be used in all future calculations of
hepatic arterial resistance.
Regardless of whether resistance is calculated using the
appropriate pressure gradient, the means of quantitating
autoregulation is still problematic. For demonstration of
autoregulation in a basal state one can use either of the
following two methods. Reduction of vascular resistance as
blood pressure is decreased (Figure 19) or calculation of the
autoregulatory index (Table 2) is useful for this purpose. In
addition, these indices showed antagonism of autoregulation by
adenosine receptor blockade. The autoregulatory index
compares flows and pressures from a standardized control state
to the shoulder of the pressure-flow curve and the calculated
value is essentially a proportional change in flow divided by
a proportional change in pressure. Of concern to us was the
fact that comparison of control and blocked state required use
of arbitrary, standardized pressure ranges to be used. In
several animals we saw a clear upward shift of autoregulatory
range when the blocking dose of a-PT was too low (the curve
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shifted to the .right). In these cases the final slope of < the
absolute pressure-flow curve appeared similar, indicating-that
autoregulation may not have been altered at higher pressures
but because the curve had· shifted to the right,comparison
with the control state would artifactually indicate blockade
of autoregulation if the resistance changes over the
standardized pressure range were compared. Others (Torrance,
1961) report shifts in the curve with curve shape being
retained. To obviate this potential artifact we introduce a
new index of autoregulation, the autoregulatory slope index.
This calculation is based on comparison of the mean slope of
the curve over the autoregulatory range divided by the mean
slope below the autoregulatory range expressed as percent (but
excluding any tailing-off of the curve near the critical
closing pressure). This is illustrated in Figure 18. A slope
index of 100% indicates a perfectly linear curve and does not
depend on the position of the curve on the pressure axis or on
other methods of standardizing the curve. The slope index in
the blocked state is calculated in the same manner,
identifying a new shoulder from the raw data. This approach
is necessary since the blockers appeared to cause the shoulder
to shift (but not consistently up or down) and by calculating
the slope index independently in control and blocked state,
bias can be eliminated. The slope index was significantly
elevated by adenosine antagonists (Table 2). Because it
avoids the need to calculate resistance, with the incumbent
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errors in such calculation, this method appears useful. The
usefullness may be even great.er in st.udies of vascular beds
TNhere a valid value for capillary pressure cannot be made
since the philosophical debate about the use of critical
closing p.ressure to calculate pressure gradient is avoided.
The principle disadvantage is that two linear slopes must be
calculated from a non-linear curve and if this is not done
mathematically, significant bias could be introduced. Several
'data points ,must, therefore, be obtained, above and below ,the
autoregulatory range. Regression calculation showed that the
small non-linearity of the curves could be readily fitted to a
straight line with correlation always greater than 0.95.
4.7 SUMMARY
The hepatic circulation is unique in that the liver
receives a dual blood supply through the hepatic artery and
portal vein. Under normal conditions the hepatic artery
contributes 25% to total hepatic blood flows. The liver has
no control over portal flow changes since portal flow' is the
sum of flows drained from prehepatic splanchnic organs.
Therefore, the hepatic artery is the only means available for
the liver to control its total blood flow. The smallest
hepatic functional unit is the acinus which is a cluster of
hepatocytes around a stalk of vascular structures and nerve
fibers. These vascular structures include portal venules,
hepatic arterioles, bile ductules and lymphatics. Blood flows
139
from the portal venules and hepatic arterioles into the
hepatic sinusoids to be collected by the terminal hepatic
venules. Flow in adjacent sinusoids is concurrent and under
3-SmmHg pressure gradient.
The existence of stable total hepa-tic blood flow is
essential for the liver to maintain its clearance and
capacitance (reservoir) functions as well as to maintain a
stable intrahepatic pressure to keep sinusoids potent and to
prevent their collapse.It was observed over seven decades
ago that the hepatic arterial flow changes, in a reciprocal
fashion, in response to changes in portal flow in order to
maintain a stable total hepatic blood flow, a phenomenon
termed recently "the hepatic arterial buffer response (HABR)".
The ability of the hepatic artery to autoregulate its own
resistance, regardless of portal flow, in response to changes
in the hepatic arterial blood pressure was still
controversial.
This stUdy was designed first, to test and quantitate the
hepatic arterial buffer response and the hepatic arterial
autoregulation. Second, to explore whether one unified
mechanism can explain both responses. An anesthetized
splenectomized cat model with intact hepatic blood supply and
nerve supply was used. The arterial flow and pressure in both
the hepatic artery and the superior mesenteric artery were
controlled mechanically through the application of a
micrometer screw clamp around. each artery. Flows were
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measured by el~ctromagnetic flow probes. Such a preparation
allowed reproducible testing for HABR and autoregulation,
however the range of testing could not be extended to higher
hepatic arterial flow levels.
The buffer capacity of the hepatic artery in response to
portal flow changes was found to be variable. A maximum value
of 24% was reached at 60% decrease in portal flow. Further
decreases in portal flow were less compensated for despite the
progressive increased' dilation of the hepatic artery. A
constant buffer capacity of 30% was achieved, regardless of
the level of portal flow changes, when pressure gradient
across the hepatic artery was left uncontrolled. The hepatic
artery is confirmed to bea weakly autoregulatory blood vessel
as well.
Both the HABR and autoregulation can be blocked in a
dose-related fashion by selective adenosine receptor
antagonists. The blockade of autoregulation is roughly in
parallel with blockade of the hepatic arterial buffer response
and the response to infused adenosine. Theoretical aspects of
quantitation of autoregulation led to the development of a new
autoregulatory slope index that relies on the slope of the
pressure-flow curve and makes no assumption about critical
closing pressure, capillary pressure or resistance
calcUlation. This new index confirmed adenosine involvement
in hepatic arterial autoregulation. The data are consistent
with the mechanism that an intrinsic regulator, namely
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adenosine, mediates theHABR and hepatic arterial
autoregulation. A unified theory of regulation of the hepatic
artery is that adenosine concentration in the fluid that
surrounds the hepatic arterial resistance vessels is regulated
primarily by washout into blood streams. 'Washout into portal
blood accounts for the hepatic arterial buffer response
whereby reduced portal flow leads to less washout and the
resultant accUlnulation of adenosine leads to arterial
filtration; washout into the hepatic artery accounts for
autoregulation whereby reduced arterial flow leads to reduced
washout and the accumulation of adenosine leads to arterial
dilation.
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5. PROSPECTIVE STUDIES
The· accomplishment of this research work left us with
many unsolved questions. Quantitation of the HABR in the
conscious cat was a project I: started with. As mentioned in
the text, I tried to measure blood flow to the liver using the
microsphere technique. I learned the technique and applied it
to conscious cats, however unexpected obstacles appeared. On
many occasions the splenic artery, similar to the hepatic
artery, dilated in response to reduced SMA flow. Therefore,
simultaneous splenic and SMA occlusion are required to test
for the HABR in conscious preparations. The behavior of the
splenic artery· raises many interesting questions about its
role in splanchnic hemodynamics and whether there is anyso.rt
of relation between the hepatic artery and the splenic artery.
Direct measurement of adenosine concentrations in the
fluid of the space of Mall is a clear target to prove or
disprove the washout theory. The suggested methodology is to
induce hepatic congestion (partial hepatic outflow occlusion)
and to test for the presence of adenosine and its metabolites
in the fluid exudate (Which includes hepatic lymph) collected
from the surface of the liver. If this technique can be
validated to measure adenosine concentration in the space of
Mall, many tests can be conducted to test for the rate of
production, the ability of the portal vein and the hepatic
artery to wash away adenosine, mechanism of release, etc.
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The study of the pharmacokinetics of adenosine deaminase
and deaminase blockers on hepatic circulation is essential.
The HABRand autoregulation should be tested during their
administration.
The most stable factor in our preparation is the portal
pressure. It remains stable despite the wide variations in
portal and hepatic arterial flow. There should be a mechanism
to regulate the postsinusoidal resistance to maintain portal
pressure constant. ,such a mechanism is not adenosine
mediated. Adenosine and other dilators seem to have no effect
on portal pressure. The portal vein only responds to
vasoconstrictors by increasing its resistance to flow (i.e.
increased portal pressure). The exploration of this field is
quite essential for the proper understanding of liver
hemodynamics.
The speculation that two adenosine pools exist in the
liver is interesting. The role of adenosine in some liver
diseases, such as cirrhosis, is of interest to a person with a
medical background, like myself. It is well known that some
liver cirrhosis is accompanied by hyperdynamic circulation.
Is it possible that cirrhotic livers are hypoxic and release
increased amounts of adenosine which leads to the decreased
peripheral resistance and the depressed cardiac contractility?
comparative stUdies to test for arterial adenosine levels in
control and cirrhotic liver models are required. The effect
of portal adenosine deaminase infusion on the systemic
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circulation in~uch cirrhotic Inodels is also required.
The microsphere technique allows the direct· b.lood flow
measurement in conscious preparations. Such a technique gives
me the chance to test for the existance of postprandial
intestinal hyperemia in cats and whether that hyperemia is
adenosine mediated or not.
Despite the great advance in the understanding of the
splanchnic hemodynamics and hepatic circulation in particular,
this field can still be considered. as a virgin land. Many
questions are still waiting to be answered. until a
comprehensive understanding of the hepatic hemodynamics can be
reached, many breakthroughs are still ahead to be discovered.
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APPENDIX A
Effect of vasoconstrictor and dilator on basal and autorequlatorjl
parameters in the hepatic artery of the anesthetized cat.
CONTROL RESPONSE ~
NOREPINEPHRINE (N=5)
basal HAC 0.156 ± 0.020 0.102 ± 0.015 **(lnl.min-l .Kq-1. mmHg-1)
CCP (mmHq) 17.8 + 1.4 23.4 ± 1.9 **
% flHAR -14.38 + 4.39 -10.34 + 5.60 NS
ARI 0.902 ± 0.088 1.046 ± 0.108 NS
Slope Index 50.45 + 3.94 72.01 ± 11.71 NS
ISOPROTERENOL (N=4)
basal HAC 0.189 + 0.019 0.247 ± 0.025 *(ml.min-1 .Kq-1. mmHq-1)
CCP (mmHq) 25.3 + 3.8 22.5 ± 2.4 NS
%flHAR -16.29 ± 6.26 10.08 + 8.93 *
ARI 1.072 ± 0.081 1.302 ± 0.068 NS
Slope Index 50.12 + 9.33 80.52 ± 19.19 NS
The vasoconstrictor response rroduced by theintraportal infusior
of norepinephrine (O.lug.min- .Kg-1) was accompanied by reductior
in autoregulatory parameter values (% fl HAR, ARI, and slope index),
however, the decrease was not siqnificant. Isoproterenol infusior
(0. 2ug .min-1.Kg-l) induced an opposite response (dilation) witt.
significant inhibition of the hepatic arterial autorequlatior
according to one parameter (%flHAR).
* = p<0.05; ** = p<O.Ol; NS = not significant.
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APPENDIX B
CONTROL DATA (Pooled from Co57 and Tin 113 Study)
Right Left Lungs Liver Pancreas Small Large Omentum Stomach
Kidney Kidney Intestine Intestine
Weight (gm) 9.12 9.45 16.74 76.00 5.72 68.07 20.93 65.30 23.30
0.51 0.51 0.85 2.67 0.26 3.76 0.91 4.50 0.98
Weight (gm/Kg b.w) 3.47 3.60 6.34 28.97 2.17 25.81 7.98 24.55 8.82
0.18 0.21 0.28 1.22 0.08 1.25 0.37 1.35 0.27
% of Cardiac Output 8.62 9.16 7.56 15.63* 0.41 15.58 4.07 1.51 0.96
0.47 0.59 1.89 1.95 0.06 1.72 0.41 0.14 0.05
Flow (ro1/Kg b.w)
Flow (rol/lOOg )
10.28
1.09
296.00
27.92
11.24
1.45
302.84
30.34
8.59
1.28
123.65
17.83
18.75t 0.50
2.98 0.08
65.27 23.93
9.01 4.40
18.99
2.32
72.02
7.68
4.75
0.62
59.88
7.58
1.78
0.20
7.20
1.01
1.09
0.09
12.34
1.11
Correlation
Coffic}ent (r) 0.957
of Co5 and Tin 113 0.026
0.865
0.048
0.973
0.012
0.850
0.032
0.804
0.039
0.900
0.034
0.973
0.017
0.876
0.041
* This data is just for HAF, Portal flow is 22.54 ± 2.20 ; Total Hepatic Blood Flow is 38.17 + 3.59 %,
t This data is for HAF, Portal flow is 27.07 + 3.09 ; Total HBF is 45.82 + 5.54
APPENDIX B
Control values (mean + SE) pooled from 19 observations. The
control values were calculated from the microsphere study
conducted to evaluate the surgical preparation in anesthetized
splenectomized cats (N=12). The average weight of cats was
2.64 ± 0.06 Kg. Two kinds of microspheres were used in this
study 57co (10 observations) and l13Sn (9 observations).
Despite the ligation of the gastric, gastroduodenal and
inferior mesenteric. arteries, the splanchnic organs maintained
an adequate blood supply. This indicates the presence of.
efficient anastamotic connections with the only remaining
patent arterial flow, the superior mesenteric artery. The
high percentage of cardiac output to the lungs indicated the
existence of significant shunts from the arterial to the
venous side, probably through the skin circulation. The
significant correlation between 57Co and 113sn activites in
each tissue sample indicates symmetrical distribution of both
kinds of microspheres , i.e. the first microspheres entrapment
did not affect the pattern of distribution of the second ones.
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APPENDIX C
Effect of SMA Occlusion on Systemic and
Splanchnic Circulation in the Anesthetized Cat
CONTROL SMA OCCLUSION
Portal Flow (ml/min) 75.28 ± 23.13 6.00 ± 1.51
Portal Flow (%) 100 8.49 ± 1.36
Pancreas 1.99 ± 0.21 6.60 + 1.87
Stomach 4.83 ± 0.71 37.96 + 12.16
S. Intestine 68.52 ± 1.49 11.63 ± 5.25
L. Intestine & 17.96 ± 1.17 36.40 ± 6.79Rectum
Omentum 6.69 + 0.52 7.41 ± 2.00
Cardiac Output 136.62 + 28.50 128.23 ± 25.03 NS(ml.min-1 .Kg-1)
Blood Pressure (nnnHg) 111.4 ± 9.7 110.6 ± 12.0 NS
Pulse (beat/min) 226.2 ± 8.9 217.8 ± 7.9" *
HAF/THBF (%) 39.63 ± 2.40 93.09 ± 0.54
The data present here are calculated from the microsphere study
(N=5) where the first batch of microspheres was administered before
SMA occlusion (control) and the second batch was administered after
the occlusion (i.e. during the hepatic arterial buffer response
(HABR) ) • Flowprobe measured portal flow (control) was 88.84 ±
27.87 ml/min. Complete occlusion of SMA left some residual portal
flow according to the microsphere study, however, the correlation
between net reduction in portal flow measured by the flowprobe and
that calculated from the microsphere technique was highly
significant (r=O.998; P<0.0001). The SMA.Occlusion did not affect
the cardiac output or the systemic blood pressure" however, the
pUlse rate decreased significantly.
NS = not significant; * = P<0.05; THBF = total hepatic blood flow.
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APPENDIX 0
Control values (Mean + SE) derived from the microsphere study
conducted on conscious cats (N=6). In this study the
splanchnic. circulation was intact and cats were fasted
overnight with free access to water. The average weight of
cats was 2.90 + 0.20 Kg. Two kinds of microspheres were used
57co (N=4) and 113Sn (N=2). The cardiac output was 219.99 ±
32.55 ml.m!n-1 .Kq-1. Portal flow was 25.89± 3.35% of the
cardiac output, or 54.77 ± 7.44 ml.min-1 .Kg-1 • Total hepatic
blood flow was 73.86 + 12.97 ml.min-1 .Kg-1 • In conscious cats
the hepatic artery contributed 23.04 ± 4.89% to total hepatic
blood flow. This value is much less than that (39.63%) in
unconscious splenectomized cats (Appendix C). Note that
splenectomy deprives the hepatic circulation of 21.79% of
portal inflow. The higher contribution of the hepatic artery
to total hepatic blood flow in the unconscious splenectomized
preparation is believed to be due to the partial stimulation
of the HABR .in response to reduced portal inflow due to
splenectomy and surgical stress.
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APPENDIX D
Large
Right Left Lungs Liver Pancreas Spleen Stomach Small Intestine Omentum
Kidney Kidney Intestine & Rectum
Weight 11.29 10.84 16.17 97.35 7.08 9.79 21.96 72.40 21.69 88.84
(gm) 0.94 0.95 0.52 4.72 0.64 0.91 1.12 6.24 1.37 14.55
Weight 3.94 3.78 5.71 34.24 2.50 3.39 7.71 25.61 7.60 29.55
(gm/Kg) 0.31 0.30 0.35 1.75 0.27 0.25 0.50 2.99 0.51 3.67
% of Cardiac 5.33 5.39 1.68 6.58* 2.01 5.55 2.26 9.45 4.17 2.46
Output 1:05 1.06 0.73 2.19 0.37 0.68 0.28 1.25 1.06 0.28
Flow -1 -1 10.83 10.96 3.60 19.08* 4.04 11.79 5.11 20.65 8.06 5.12(mI. min •Kg ) 1.67 1.77 1.58 6.63 0.41 1.97 1.09 3.62 1.38 0.56
Flow
-1 -1 269.04 286.90 63.00 50.40* 191.33 403.57 76.17 112.32 115.58 19.73(ml.min .100g ) 29.61 32.38 28.42 15.35 24.00 92.90 18.81 28.20 16.37 3.71
% of Portal 7.65 21.79 8.82 36.48 15.36 9.89
Flow 0.58 1.76 0.86 1.97 2.23 1.34
* Data represent that of the hepatic artery only.
